Teleflex (TFX) 10-Q 28 Apr 16 2016 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 27, 2016	Apr. 25, 2016
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 27, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q1
Trading Symbol	TFX
Entity Registrant Name	TELEFLEX INCORPORATED
Entity Central Index Key	96,943
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		43,595,541

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Income Statement [Abstract]
Net revenues	$ 424,893	$ 429,430
Cost of goods sold	199,746	206,793
Gross profit	225,147	222,637
Selling, general and administrative expenses	136,348	139,697
Research and development expenses	12,353	12,884
Restructuring charges	9,968	4,448
Gain on sale of assets	(1,019)	0
Income from continuing operations before interest and taxes	67,497	65,608
Interest expense	13,784	17,172
Interest income	(80)	(169)
Income from continuing operations before taxes	53,793	48,605
Taxes on income from continuing operations	2,613	9,332
Income from continuing operations	51,180	39,273
Operating loss from discontinued operations	(382)	(499)
(Benefit) taxes on loss from discontinued operations	(70)	204
Loss from discontinued operations	(312)	(703)
Net income	50,868	38,570
Less: Income from continuing operations attributable to noncontrolling interest	179	218
Net income attributable to common shareholders	$ 50,689	$ 38,352
Basic:
Income from continuing operations (in dollars per share)	$ 1.22	$ 0.94
Loss from discontinued operations (in dollars per share)	0	(0.02)
Net income (in dollars per share)	1.22	0.92
Diluted:
Income from continuing operations (in dollars per share)	1.05	0.83
Loss from discontinued operations (in dollars per share)	(0.01)	(0.02)
Net income (in dollars per share)	1.04	0.81
Dividends per share (in dollars per share)	$ 0.34	$ 0.34
Weighted average common shares outstanding
Basic (in shares)	41,647	41,469
Diluted (in shares)	48,782	47,295
Amounts attributable to common shareholders:
Income from continuing operations, net of tax	$ 51,001	$ 39,055
Loss from discontinued operations, net of tax	(312)	(703)
Net income attributable to common shareholders	$ 50,689	$ 38,352

CONDENSED CONSOLIDATED STATEME3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Statement of Comprehensive Income [Abstract]
Net income	$ 50,868	$ 38,570
Other comprehensive income (loss), net of tax:
Foreign currency translation, net of tax of $(4,177) and $23,438	20,455	(83,090)
Pension and other postretirement benefit plans adjustment, net of tax of $(629) and $(886)	1,238	1,906
Derivatives qualifying as hedges, net of tax of $(379) and $(25)	1,480	44
Other comprehensive income (loss), net of tax:	23,173	(81,140)
Comprehensive income (loss)	74,041	(42,570)
Less: comprehensive income attributable to non-controlling interest	158	279
Comprehensive income (loss) attributable to common shareholders	$ 73,883	$ (42,849)

CONDENSED CONSOLIDATED STATEME4

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Statement of Comprehensive Income [Abstract]
Foreign currency translation, tax	$ (4,177)	$ 23,438
Pension and other postretirement benefits plans adjustment, tax	(629)	(886)
Derivatives qualifying as hedges, tax	$ (379)	$ (25)

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 27, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents	$ 392,558	$ 338,366
Accounts receivable, net	274,660	262,416
Inventories, net	338,906	330,275
Prepaid expenses and other current assets	40,733	34,915
Prepaid taxes	31,098	30,895
Assets held for sale	7,054	6,972
Total current assets	1,085,009	1,003,839
Property, plant and equipment, net	318,183	316,123
Goodwill	1,303,456	1,295,852
Intangible assets, net	1,188,853	1,199,975
Investments in affiliates	196	152
Deferred tax assets	2,358	2,341
Other assets	45,411	53,492
Total assets	3,943,466	3,871,774
Current liabilities
Current borrowings	421,198	417,350
Accounts payable	73,313	66,305
Accrued expenses	68,797	64,017
Current portion of contingent consideration	7,397	7,291
Payroll and benefit-related liabilities	72,031	84,658
Accrued interest	6,635	7,480
Income taxes payable	12,700	8,059
Other current liabilities	12,604	8,960
Total current liabilities	674,675	664,120
Long-term borrowings	641,973	641,850
Deferred tax liabilities	322,043	315,983
Pension and postretirement benefit liabilities	146,804	149,441
Noncurrent liability for uncertain tax provisions	26,168	40,400
Other liabilities	57,728	48,887
Total liabilities	$ 1,869,391	$ 1,860,681
Commitments and contingencies
Mezzanine equity	$ 12,877	$ 0
Total common shareholders' equity	2,059,219	2,009,272
Noncontrolling interest	1,979	1,821
Total equity	2,061,198	2,011,093
Total liabilities and equity	$ 3,943,466	$ 3,871,774

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Cash flows from operating activities of continuing operations
Net income	$ 50,868	$ 38,570
Adjustments to reconcile net income to net cash provided by operating activities:
Loss from discontinued operations	312	703
Depreciation expense	12,602	10,915
Amortization expense of intangible assets	15,357	14,740
Amortization expense of deferred financing costs and debt discount	4,377	4,195
Gain on sale of assets	(1,019)	0
Changes in contingent consideration	377	382
Stock-based compensation	3,437	3,832
Deferred income taxes, net	756	1,085
Other	(3,114)	(4,294)
Changes in operating assets and liabilities, net of effects of acquisitions and disposals:
Accounts receivable	(10,568)	(21,906)
Inventories	(5,104)	(14,578)
Prepaid expenses and other current assets	(3,749)	(4,756)
Accounts payable and accrued expenses	4,502	3,819
Income taxes receivable and payable, net	(2,202)	9,651
Net cash provided by operating activities from continuing operations	66,832	42,358
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(7,822)	(14,445)
Proceeds from sale of assets	1,251	0
Payments for businesses and intangibles acquired, net of cash acquired	0	(7,375)
Net cash used in investing activities from continuing operations	(6,571)	(21,820)
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings	0	30,000
Reduction in borrowings	(9)	(52)
Net proceeds from share based compensation plans and the related tax impacts	3,180	(289)
Payments for contingent consideration	(61)	(3,989)
Dividends paid	(14,179)	(14,118)
Net cash used in financing activities from continuing operations	(11,069)	11,552
Cash flows from discontinued operations:
Net cash used in operating activities	(126)	(1,126)
Net cash used in discontinued operations	(126)	(1,126)
Effect of exchange rate changes on cash and cash equivalents	5,126	(25,441)
Net increase in cash and cash equivalents	54,192	5,523
Cash and cash equivalents at the beginning of the period	338,366	303,236
Cash and cash equivalents at the end of the period	$ 392,558	$ 308,759

CONDENSED CONSOLIDATED STATEME7

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid In Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Noncontrolling Interest
Beginning Balance at Dec. 31, 2014					$ (260,895)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 38,570
Other comprehensive (loss) income	(81,140)
Ending Balance at Mar. 29, 2015					(342,096)
Beginning Balance (in shares) at Dec. 31, 2015		43,517				1,908
Beginning Balance at Dec. 31, 2015	2,011,093	$ 43,517	$ 440,127	$ 2,016,176	(371,124)	$ (119,424)	$ 1,821
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	50,868			50,689			179
Cash dividends ($0.34 per share)	(14,179)			(14,179)
Other comprehensive (loss) income	$ 23,173				23,194		$ (21)
Distributions to noncontrolling interest shareholders
Settlements of convertible notes	$ 0		(5)			5
Settlements of note hedges associated with convertible notes	1		11			$ (10)
Reclassification of convertible notes to mezzanine equity	(12,877)		(12,877)
Shares issued under compensation plans (in shares)		62				41
Shares issued under compensation plans	3,043	$ 62	2,413			$ 568
Deferred compensation (in shares)						(2)
Deferred compensation	76					$ 76
Ending Balance (in shares) at Mar. 27, 2016		43,579				1,865
Ending Balance at Mar. 27, 2016	$ 2,061,198	$ 43,579	$ 429,669	$ 2,052,686	$ (347,930)	$ (118,785)	$ 1,979

CONDENSED CONSOLIDATED STATEME8

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) - $ / shares	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Statement of Stockholders' Equity [Abstract]
Dividends per share (in dollars per share)	$ 0.34	$ 0.34

Basis of presentation

Basis of presentation	3 Months Ended
	Mar. 27, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Note 1 — Basis of presentation The accompanying unaudited condensed consolidated financial statements of Teleflex Incorporated and its subsidiaries are prepared on the same basis as the annual consolidated financial statements. In the opinion of management, the financial statements reflect all adjustments, which are of a normal recurring nature, necessary for the fair statement of financial statements for interim periods in accordance with accounting principles generally accepted in the United States of America ("GAAP") and with Rule 10-01 of SEC Regulation S-X, which sets forth the instructions for financial statements included in Form 10-Q. The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. In accordance with applicable accounting standards, the accompanying condensed consolidated financial statements do not include all of the information and footnote disclosures that are required to be included in the Company's annual consolidated financial statements. The year-end condensed consolidated balance sheet data was derived from the Company's audited financial statements, but, as permitted by Rule 10-01 of SEC Regulation S-X, does not include all disclosures required by GAAP for complete financial statements. Accordingly, the Company's quarterly condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2015 . Effective April 1, 2015, the Company reorganized certain of its businesses to better leverage the Company’s resources. As a result, the Company realigned its operating segments and segment data included in Notes 3, 5 and 13 has been restated to reflect these changes. See Note 13 for additional information, including information regarding changes in the composition of certain of the Company's reportable operating segments. As used in this report, the terms “we,” “us,” “our,” “Teleflex” and the “Company” mean Teleflex Incorporated and its subsidiaries, unless the context indicates otherwise. The results of operations for the periods reported are not necessarily indicative of those that may be expected for a full year.

New accounting standards

New accounting standards	3 Months Ended
	Mar. 27, 2016
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
New accounting standards	New accounting standards In May 2014, the Financial Accounting Standards Board ("FASB"), in a joint effort with the International Accounting Standards Board ("IASB"), issued new accounting guidance to clarify the principles for recognizing revenue. The new guidance is designed to enhance the comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, and will affect any entity that enters into contracts with customers or enters into contracts for the transfer of nonfinancial assets, unless those contracts are within the scope of other standards. The new guidance establishes principles for reporting information to users of financial statements about the nature, amount, timing, and uncertainty of revenue and cash flows arising from an entity's contracts with customers. The core principle of the new guidance is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued an amendment to the new guidance that defers the effective date. The amendment provides that the new guidance is effective prospectively for annual periods beginning after December 15, 2017 and interim periods within those years; early application is permitted for annual periods beginning after December 15, 2016. The Company is currently evaluating this guidance to determine its impact on the Company’s results of operations, cash flows and financial position. In April 2015, the FASB issued guidance for the reporting of debt issuance costs within the balance sheet. Under the new guidance, debt issuance costs related to term loans are to be presented in the balance sheet as a direct deduction from the associated debt liability, consistent with the presentation of a debt discount. Previously, debt issuance costs were presented as a deferred charge (i.e., an asset) on the balance sheet. The guidance provides uniform treatment for debt issuance costs and debt discounts and eliminates inconsistencies that previously existed with other FASB guidance. The Company retrospectively adopted this guidance as of January 1, 2016. In February 2016, the FASB issued guidance that will change the requirements for accounting for leases. The principal change under the new accounting guidance is that lessees under leases classified as operating leases will recognize a right-of-use asset and a lease liability. Current lease accounting does not require lessees to recognize assets and liabilities arising under operating leases on the balance sheet. Under the new guidance, lessees (including lessees under leases classified as finance leases and operating leases) will recognize a right-to-use asset and a lease liability on the balance sheet, initially measured as the present value of lease payments under the lease. Expense recognition and cash flow presentation guidance will be based upon whether the lease is classified as an operating lease or a finance lease (the classification criteria for distinguishing between finance leases and operating leases is substantially similar to the classification criteria for distinguishing between capital leases and operating leases under current guidance). The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition approach for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements; the guidance provides certain practical expedients. The Company is currently evaluating this guidance to determine its impact on the Company’s results of operations, cash flows and financial position. In March 2016, the FASB issued new guidance designed to simplify several aspects of the accounting for share-based payment transactions, including guidance relating to accounting for income taxes with respect to share-based payment awards; providing generally that excess tax benefits related to share-based awards should be recorded as a reduction to income tax expense (currently, excess tax benefits generally are recorded to additional-paid-in-capital); providing generally that excess tax benefits related to share-based awards should be classified along with other income tax cash flows as an operating activity (currently, excess tax benefits generally are separated from other income tax cash flows and classified as a financing activity); providing that an entity may make an accounting policy election either to base compensation cost accruals on the number of awards expected to vest (as required by current guidance) or to account for forfeitures when they occur; modifying the current exception to liability classification such that partial cash settlement of an award for tax withholding purposes would not result, by itself, in liability classification of the award if the amount withheld does not exceed the maximum statutory tax rate in the employees' applicable jurisdictions (currently, an award cannot qualify for equity classification, rather than liability classification, if the amount withheld exceeds the minimum statutory withholding requirements); and providing that cash paid by an employer when directly withholding shares for tax withholding purposes should be classified as a financing activity on the statement of cash flows (currently there is no authoritative guidance addressing this classification issue). The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted (if early adoption occurs in an interim period, any adjustments will be reflected as of the beginning of the fiscal year that includes the interim period). Depending on the particular issue addressed by the guidance, application of the guidance will be made prospectively, retrospectively or subject to a retrospective transition method. We are currently evaluating the potential impact of adopting this guidance on the Company's results of operations, cash flows and financial position. From time to time, new accounting guidance is issued by the FASB or other standard setting bodies that is adopted by the Company as of the effective date or, in some cases where early adoption is permitted, in advance of the effective date. The Company has assessed the recently issued guidance that is not yet effective and, unless otherwise indicated above, believes the new guidance will not have a material impact on the Company’s results of operations, cash flows or financial position.

Restructuring charges

Restructuring charges	3 Months Ended
	Mar. 27, 2016
Restructuring and Related Activities [Abstract]
Restructuring charges	Note 3 — Restructuring charges 2016 Manufacturing Footprint Realignment Plan On February 23, 2016, the Board of Directors of the Company approved a restructuring plan (the “2016 Plan") designed to reduce costs, improve operating efficiencies and enhance the Company’s long term competitive position. The 2016 Plan, which was developed in response to continuing cost pressures in the healthcare industry, involves the consolidation of operations and a related reduction in workforce at certain of the Company’s facilities, and will primarily include the relocation of certain manufacturing locations and relocation and outsourcing of certain distribution operations. These actions commenced in the quarter ended March 27, 2016 and are expected to be substantially completed by the end of 2018. The Company estimates that it will incur aggregate pre-tax charges in connection with the 2016 Plan of between approximately $34 million to $44 million , of which an estimated $27 million to $31 million are expected to result in future cash outlays. Most of these charges, and the related cash outlays, are expected to be made prior to the end of 2018. The following table provides a summary of the Company's current cost estimates for each major expense category associated with the 2016 Plan: Type of expense Total estimated amount expected to be incurred Employee termination benefits $14 million to $18 million Facility closure and other exit costs (1) $2 million to $3 million Accelerated depreciation charges $10 million to $13 million Other (2) $8 million to $10 million $34 million to $44 million (1) Includes costs to transfer product lines among facilities, legal, outplacement and employee relocation costs. (2) Consists of other costs directly related to the 2016 Plan, including project management and other regulatory costs. The Company recorded charges of $10.9 million during the three months ended March 27, 2016 related to the 2016 Plan, of which $10.3 million related to employee termination benefits and was recorded as a restructuring expense and $0.6 million related to accelerated depreciation and other costs and primarily was recorded as cost of goods sold. As the 2016 Plan progresses, management will reevaluate the estimated expenses set forth above, and may revise its estimates, as appropriate, consistent with GAAP. 2015 Restructuring Programs During 2015, the Company committed to programs associated with the reorganization of certain of its businesses, as discussed in Note 13, and the consolidation of certain of its facilities in North America. For the three months ended March 27, 2016 , the Company recorded charges of $0.2 million related to these programs. As of March 27, 2016, the Company has incurred net aggregate restructuring charges related to the plan of $6.5 million . As of March 27, 2016 , the Company has a reserve of $1.8 million related to these programs. 2014 Manufacturing Footprint Realignment Plan In April 2014, the Board of Directors approved a restructuring plan (the “2014 Manufacturing Footprint Realignment Plan”) involving the consolidation of operations and a related reduction in workforce at certain of the Company’s facilities, and the relocation of manufacturing operations from certain higher-cost locations to existing lower-cost locations. The Company recorded charges of $1.6 million for the three months ended March 27, 2016 related to the 2014 Manufacturing Footprint Realignment Plan. This amount reflects $2.1 million that was included in cost of goods sold and related to accelerated depreciation and certain other costs resulting from the plan, offset by a $0.5 million reversal of previously recorded restructuring expense. As of March 27, 2016, the Company has incurred net aggregate restructuring charges related to the plan of $10.4 million . Additionally, as of March 27, 2016, the Company has incurred net aggregate accelerated depreciation and certain other costs in connection with the plan of $16.5 million , which were primarily included in cost of goods sold. As of March 27, 2016 , the Company has a restructuring reserve of $6.5 million in connection with the plan, all of which relates to termination benefits. The restructuring charges recognized for the three months ended March 27, 2016 and March 29, 2015 consisted of the following: Three Months Ended March 27, 2016 (in thousands) Termination Benefits Facility Contract Termination Costs Other Exit Costs Total 2016 Manufacturing footprint realignment plan $ 10,347 $ — $ — $ — $ 10,347 2015 Restructuring programs 43 123 (22 ) 93 237 2014 Manufacturing footprint realignment plan (538 ) — — 2 (536 ) Other restructuring programs - prior years (1) — — (86 ) 6 (80 ) Total restructuring charges $ 9,852 $ 123 $ (108 ) $ 101 $ 9,968 Three Months Ended March 29, 2015 (in thousands) Termination Benefits Facility Closure Costs Contract Termination Costs Other Exit Costs Total 2015 Restructuring programs $ 3,550 $ 67 $ 621 $ — $ 4,238 2014 Manufacturing footprint realignment plan 137 22 — 4 163 Other restructuring programs - prior years (1) 12 — 18 17 47 Total restructuring charges $ 3,699 $ 89 $ 639 21 $ 4,448 (1) Other restructuring programs - prior years includes the 2014 European Restructuring Plan, the Other 2014 restructuring programs, the 2013 Restructuring programs and the LMA restructuring program. For a description of these plans, see Note 4 to the Company’s consolidated financial statements included in its annual report on Form 10-K for the year ended December 31, 2015. Termination benefits include estimated employee retention, severance and benefit payments for terminated employees. Facility closure costs include general operating costs incurred subsequent to production shutdown as well as legal costs, equipment relocation and other associated costs. Contract termination costs include costs associated with terminating existing leases and distributor agreements. Other costs include outplacement and employee relocation costs and other employee-related costs. Restructuring charges by reportable operating segment for the three months ended March 27, 2016 and March 29, 2015 are set forth in the following table: Three Months Ended March 27, 2016 March 29, 2015 (Dollars in thousands) Restructuring charges Vascular North America $ 4,163 $ 2,263 Anesthesia North America 1,875 537 Surgical North America (19 ) 23 EMEA 3,872 (32 ) Asia 2 — OEM 4 — All other 71 1,657 Total restructuring charges $ 9,968 $ 4,448

Inventories, net

Inventories, net	3 Months Ended
	Mar. 27, 2016
Inventory Disclosure [Abstract]
Inventories, net	Inventories, net Inventories as of March 27, 2016 and December 31, 2015 consisted of the following: March 27, 2016 December 31, 2015 (Dollars in thousands) Raw materials $ 79,405 $ 76,037 Work-in-process 58,729 60,218 Finished goods 237,661 230,536 375,795 366,791 Less: inventory reserve (36,889 ) (36,516 ) Inventories, net $ 338,906 $ 330,275

Goodwill and other intangible a

Goodwill and other intangible assets, net	3 Months Ended
	Mar. 27, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and other intangible assets, net	Note 5 — Goodwill and other intangible assets, net The following table provides information relating to changes in the carrying amount of goodwill by reportable segment for the three months ended March 27, 2016 : Vascular Anesthesia Surgical EMEA Asia OEM All Total (Dollars in thousands) Balance as of December 31, 2015 $ 345,546 $ 141,122 $ 250,912 $ 306,009 $ 141,067 $ 1,194 $ 110,002 $ 1,295,852 Currency translation adjustment — 349 — 2,848 4,624 — (217 ) 7,604 Balance as of March 27, 2016 $ 345,546 $ 141,471 $ 250,912 $ 308,857 $ 145,691 $ 1,194 $ 109,785 $ 1,303,456 The following table provides information as of March 27, 2016 and December 31, 2015 regarding the gross carrying amount of, and accumulated amortization relating to, intangible assets, net: Gross Carrying Amount Accumulated Amortization March 27, 2016 December 31, 2015 March 27, 2016 December 31, 2015 (Dollars in thousands) Customer relationships $ 623,151 $ 621,078 $ (222,109 ) $ (214,924 ) In-process research and development 58,908 58,908 — — Intellectual property 523,287 522,374 (181,482 ) (173,903 ) Distribution rights 23,376 23,279 (14,767 ) (14,393 ) Trade names 387,088 384,821 (10,202 ) (8,929 ) Non-compete agreements 2,223 2,186 (620 ) (522 ) $ 1,618,033 $ 1,612,646 $ (429,180 ) $ (412,671 ) In May 2012, the Company acquired Semprus BioSciences Corp. ("Semprus"), a biomedical research and development company that developed a polymer surface treatment technology intended to reduce thrombus related complications. As previously disclosed, the Company experienced difficulties with respect to the development of the Semprus technology, and devoted further research and testing towards attempting to resolve the issue. As a result of these efforts, the Company believes it has resolved the issue and is focused on seeking regulatory approval and engaging in additional research and development efforts to achieve commercialization of the technology. Despite the progress made since these issues were first identified, significant challenges to commercialization of the Semprus technology remain, and the Company ultimately may find it necessary to recognize impairment charges with respect to the related assets, which could be material. As of March 27, 2016 , the Company has in-process research and development intangible assets of $41.0 million related to this investment, which is recorded in intangible assets, net. Amortization expense related to intangible assets were $15.4 million and $14.7 million for the three months ended March 27, 2016 and March 29, 2015 , respectively.

Borrowings

Borrowings	3 Months Ended
	Mar. 27, 2016
Debt Disclosure [Abstract]
Borrowings	Note 6 — Borrowings The Company's borrowings at March 27, 2016 and December 31, 2015 are as follows: March 27, 2016 December 31, 2015 (Dollars in thousands) Senior Credit Facility: Revolving credit facility, at a rate of 2.02% at March 27, 2016, due 2018 $ 396,000 $ 396,000 3.875% Convertible Senior Subordinated Notes due 2017 (1) 399,632 399,641 5.25% Senior Notes due 2024 250,000 250,000 Securitization program, at a rate of 1.19% at March 27, 2016 43,300 43,300 1,088,932 1,088,941 Less: Unamortized debt discount on 3.875% Convertible Senior Subordinated Notes due 2017 (19,532 ) (22,999 ) Less: Unamortized debt issuance costs (6,229 ) (6,742 ) 1,063,171 1,059,200 Current borrowings (421,198 ) (417,350 ) Long-term borrowings $ 641,973 $ 641,850 (1) The aggregate outstanding principal amount of the 3.875% Convertible Senior Subordinated Notes due 2017 (the "Convertible Notes") shown in the table above has not been reduced to reflect conversion notices received by the Company in respect of $44.3 million in aggregate principal amount of the Convertible Notes because the conversions were not settled as of March 27, 2016. For a discussion regarding the classification of the Convertible Notes as a current liability, see Note 8 to the Company's consolidated financial statements included in its annual report on Form 10-K for the year ended December 31, 2015. See Note 15 for information regarding the reduction in the outstanding principal amount of Convertible Notes subsequent to the balance sheet date as a result of the Company's exchange of cash and shares of common stock and the related reduction in the number of call options and warrants outstanding under the convertible note hedge and warrant agreements. Fair Value of Long-Term Borrowings To determine the fair value of the debt categorized as Level 2 in the table below, the Company uses a discounted cash flow technique that incorporates a market interest yield curve with adjustments for duration, optionality and risk profile. The Company’s implied credit rating is a factor in determining the market interest yield curve. The following table provides the fair value of the Company’s debt as of March 27, 2016 and December 31, 2015, categorized by the level of inputs within the fair value hierarchy used to measure fair value (see Note 10, “Fair value measurement,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 for further information): March 27, 2016 December 31, 2015 (Dollars in thousands) Level 1 $ 987,491 $ 858,709 Level 2 695,928 687,072 Total $ 1,683,419 $ 1,545,781

Financial instruments

Financial instruments	3 Months Ended
	Mar. 27, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial instruments	Financial instruments Foreign Currency Forward Contracts Designated as Cash Flow Hedges The Company uses derivative instruments for risk management purposes. Foreign currency forward contracts are used to manage foreign currency transaction exposure. These derivative instruments are designated as cash flow hedges and are recorded on the condensed consolidated balance sheet at fair market value. The effective portion of the gains or losses on derivatives is reported as a component of other comprehensive loss and thereafter is recognized in the condensed consolidated statement of income in the period or periods during which the hedged transaction affects earnings. Gains and losses on the derivatives representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness, if any, are recognized in the condensed consolidated statement of income in the period in which such gains and losses occur. Non-designated Foreign Currency Forward Contracts During the third quarter 2015, the Company began using foreign currency forward contracts as a part of its strategy to manage exposure related to near term foreign currency denominated monetary assets and liabilities. These currency forward contracts are not designated as cash flow, fair value or net investment hedges; therefore, the changes in fair value are recorded in the condensed consolidated statement of income as a selling, general and administrative expense. The Company enters into foreign currency forward contracts for periods consistent with currency transaction exposures, approximately one month. For the three months ended March 27, 2016 , the Company recognized a loss related to non-designated foreign currency forward contracts of $0.3 million . The following table presents the location of derivative financial instruments reported in the condensed consolidated balance sheet as of March 27, 2016 and December 31, 2015 : March 27, 2016 December 31, 2015 Fair Value Fair Value (Dollars in thousands) Asset derivatives: Designated foreign currency forward contracts $ 2,252 $ 285 Non-designated foreign currency forward contracts 259 44 Prepaid expenses and other current assets $ 2,511 $ 329 Total asset derivatives $ 2,511 $ 329 Liability derivatives: Designated foreign currency forward contracts $ 1,705 $ 807 Non-designated foreign currency forward contracts 168 491 Other current liabilities $ 1,873 $ 1,298 Total liability derivatives $ 1,873 $ 1,298 The total notional amount for all open foreign currency forward contracts designated as cash flow hedges as of March 27, 2016 and December 31, 2015 was $144.6 million and $49.5 million , respectively. The total notional amount for all open non-designated foreign currency forward contracts as of March 27, 2016 and December 31, 2015 was $ 78.3 million and $69.1 million , respectively. All open foreign currency forward contracts as of March 27, 2016 have durations of nine months or less. The following table provides information as to the gains and losses attributable to derivatives in cash flow hedging relationships that were reported in other comprehensive income (loss) (“OCI”) for the three months ended March 27, 2016 and March 29, 2015 : After Tax Gain (Loss) Recognized in OCI Three Months Ended March 27, 2016 March 29, 2015 Foreign currency forward contracts $ 1,480 $ 44 Total $ 1,480 $ 44 See Note 9 for information on the location in the condensed consolidated statements of income and amount of gains attributable to derivatives that were reclassified from accumulated other comprehensive loss (“AOCL”) to expense (income), net of tax. There was no ineffectiveness related to the Company’s hedging derivatives during the three months ended March 27, 2016 and March 29, 2015 . Concentration of Credit Risk Concentrations of credit risk with respect to trade accounts receivable are generally limited due to the Company’s large number of customers and their diversity across many geographic areas. A portion of the Company’s trade accounts receivable outside the United States, however, include sales to government-owned or supported healthcare systems in several countries which are subject to payment delays. Payment is dependent upon the creditworthiness of those countries and the financial stability of their economies. An allowance for doubtful accounts is maintained for accounts receivable based on the Company’s historical collection experience and expected collectability of the accounts receivable, considering the time an account is outstanding, the financial position of the customer and information provided by credit rating services. The adequacy of this allowance is reviewed each reporting period and adjusted as necessary. The allowance for doubtful accounts was $8.4 million and $8.0 million at March 27, 2016 and December 31, 2015 , respectively. The current portion of the allowance for doubtful accounts at March 27, 2016 and December 31, 2015 of $1.0 million and $2.0 million , respectively, was presented as part of accounts receivable, net. The allowance for doubtful accounts on receivables outstanding for greater than one year at March 27, 2016 and December 31, 2015 of $6.3 million and $6.0 million , respectively, was presented as part of other assets. Certain of the Company’s customers, particularly in Europe, have extended or delayed payments for products and services already provided, raising collectability concerns regarding the Company’s accounts receivable from these customers, for the most part in Greece, Italy, Spain and Portugal. As a result, the Company continues to closely monitor the allowance for doubtful accounts in these locations. The aggregate net current and long-term accounts receivable for customers in Greece, Italy, Spain and Portugal and the percentage of the Company’s total net current and long-term accounts receivable represented by the net current and long-term accounts receivable for customers in those countries at March 27, 2016 and December 31, 2015 are as follows: March 27, 2016 December 31, 2015 (Dollars in thousands) Current and long-term accounts receivable (net of allowances of $7.3 million and $7.2 million at March 27, 2016 and December 31, 2015, respectively) in Greece, Italy, Spain and Portugal (1) $ 70,343 $ 62,272 Percentage of total net current and long-term accounts receivable - Greece, Italy, Spain and Portugal 25.6 % 23.9 % (1) The long-term portion of accounts receivable, net from customers in Greece, Italy, Spain and Portugal at March 27, 2016 and December 31, 2015 was $9.6 million and $8.1 million , respectively, and is reported on the condensed consolidated balance sheet in other assets. For the three months ended March 27, 2016 and March 29, 2015 , net revenues from customers in Greece, Italy, Spain and Portugal were $30.9 million and $33.0 million , respectively.

Fair value measurement

Fair value measurement	3 Months Ended
	Mar. 27, 2016
Fair Value Disclosures [Abstract]
Fair value measurement	Fair value measurement For a description of the fair value hierarchy, see Note 10 to the Company’s 2015 consolidated financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2015 . The following tables provide information regarding the financial assets and liabilities measured at fair value on a recurring basis as of March 27, 2016 and December 31, 2015 : Total carrying Quoted prices in active markets (Level 1) Significant other Significant (Dollars in thousands) Investments in marketable securities $ 7,007 $ 7,007 $ — $ — Derivative assets 2,511 — 2,511 — Derivative liabilities 1,873 — 1,873 — Contingent consideration liabilities 21,145 — — 21,145 Total carrying Quoted prices in active markets (Level 1) Significant other Significant (Dollars in thousands) Investments in marketable securities $ 6,922 $ 6,922 $ — $ — Derivative assets 329 — 329 — Derivative liabilities 1,298 — 1,298 — Contingent consideration liabilities 20,829 — — 20,829 There were no transfers of financial assets or liabilities reported at fair value among Level 1, Level 2 or Level 3 within the fair value hierarchy during the three months ended March 27, 2016 . The following table provides information regarding changes, during the three months ended March 27, 2016 , in Level 3 financial liabilities related to contingent consideration in connection with various Company acquisitions: Contingent consideration 2016 (Dollars in thousands) Balance - December 31, 2015 $ 20,829 Payment (61 ) Revaluations 377 Balance - March 27, 2016 $ 21,145 Valuation Techniques The Company’s financial assets valued based upon Level 1 inputs are comprised of investments in marketable securities held in trust, which are available to satisfy benefit obligations under Company benefit plans and other arrangements. The investment assets of the trust are valued using quoted market prices. The Company’s financial assets and liabilities valued based upon Level 2 inputs are comprised of foreign currency forward contracts. The Company uses foreign currency forward contracts to manage foreign currency transaction exposure as well as exposure to foreign currency denominated monetary assets and liabilities. The Company measures the fair value of the foreign currency forward contracts by calculating the amount required to enter into offsetting contracts with similar remaining maturities, based on quoted market prices, and taking into account the creditworthiness of the counterparties. The Company’s financial liabilities valued based upon Level 3 inputs are comprised of contingent consideration arrangements pertaining to the Company’s acquisitions. The Company accounts for contingent consideration in accordance with applicable accounting guidance related to business combinations. In connection with several of its acquisitions, the Company agreed to pay contingent consideration upon the achievement of specified objectives, including receipt of regulatory approvals, commercialization of a product or achievement of sales targets, and recorded contingent consideration liabilities at the time of the acquisitions. The Company determines the fair value of the liabilities for contingent consideration based on a probability-weighted discounted cash flow analysis. This fair value measurement is based on significant inputs not observable in the market and, therefore, represents a Level 3 measurement within the fair value hierarchy. The fair value of the contingent consideration liability associated with future payments under contingent consideration arrangements is based on several factors, including: l estimated cash flows projected from the success of market launches; l the estimated time and resources needed to complete the development of acquired technologies; l the uncertainty of obtaining regulatory approvals within the required time periods; and l the risk adjusted discount rate for fair value measurement. In connection with the Company's contingent consideration arrangements, the Company estimates that it will make payments from 2016 through 2029. As of March 27, 2016 , the range of undiscounted amounts the Company could be required to pay under contingent consideration arrangements is between $7.0 million and $57.7 million . The Company is required to reevaluate the fair value of contingent consideration each reporting period based on new developments and record changes in fair value until such consideration is satisfied through payment upon the achievement of the specified objectives or is no longer payable due to failure to achieve the specified objectives. The following table provides information regarding the valuation techniques and inputs used in determining the fair value of assets or liabilities categorized as Level 3 measurements as of March 27, 2016 : Valuation Technique Unobservable Input Range (Weighted Average) Contingent consideration Discounted cash flow Discount rate 2.6% - 10% (8.3%) Contingent consideration Probability of payment 0% - 100% (52.7%) As of March 27, 2016 , the Company recorded $21.1 million of total liabilities for contingent consideration, of which $7.4 million was recorded as the current portion of contingent consideration and $13.7 million was recorded as other liabilities in the condensed consolidated balance sheet.

Changes in shareholders' equity

Changes in shareholders' equity	3 Months Ended
	Mar. 27, 2016
Equity [Abstract]
Changes in shareholders' equity	Changes in shareholders’ equity Basic earnings per share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed in the same manner except that the weighted average number of shares is increased to include dilutive securities. The following table provides a reconciliation of basic to diluted weighted average shares outstanding: Three Months Ended March 27, 2016 March 29, 2015 (Shares in thousands) Basic 41,647 41,469 Dilutive effect of share-based awards 519 467 Dilutive effect of 3.875% Convertible Notes and warrants 6,616 5,359 Diluted 48,782 47,295 Weighted average shares that were antidilutive and therefore not included in the calculation of earnings per share were 5.2 million and 5.8 million for the three months ended March 27, 2016 and March 29, 2015 , respectively. In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge and warrant agreements. The convertible note hedge economically reduces the dilutive impact of the Convertible Notes. However, applicable accounting guidance requires the Company to separately analyze the impact of the warrants issued under the warrant agreements on diluted weighted average shares outstanding, without giving effect to the anti-dilutive impact of the call options. The reduction in diluted shares that would result from including the anti-dilutive impact of the call options would have been 3.6 million and 3.1 million for the three months ended March 27, 2016 and March 29, 2015 , respectively. The treasury stock method is applied when the warrants are in the money and assumes the proceeds from the exercise of the warrants are used to repurchase shares based on the average stock price during the period. The exercise price of the warrants is approximately $74.65 per share of common stock. Shares issuable upon exercise of the warrants that were included in the total diluted shares outstanding were 3.0 million and 2.3 million for the three months ended March 27, 2016 and March 29, 2015 , respectively. See Note 15 for information regarding the reduction in the outstanding principal amount of Convertible Notes as a result of the Company's exchange of cash and shares of common stock and the related reduction in the number of call options and warrants outstanding under the convertible note hedge and warrant agreements. The following tables provide information relating to the changes in accumulated other comprehensive loss, net of tax, for the three months ended March 27, 2016 and March 29, 2015 : Cash Flow Hedges Pension and Other Postretirement Benefit Plans Foreign Currency Translation Adjustment Accumulated Other Comprehensive (Loss) Income (Dollars in thousands) Balance as of December 31, 2015 $ (2,491 ) $ (138,887 ) $ (229,746 ) $ (371,124 ) Other comprehensive income (loss) before reclassifications (50 ) 182 20,476 20,608 Amounts reclassified from accumulated other comprehensive (loss) income 1,530 1,056 — 2,586 Net current-period other comprehensive income 1,480 1,238 20,476 23,194 Balance as of March 27, 2016 $ (1,011 ) $ (137,649 ) $ (209,270 ) $ (347,930 ) Cash Flow Hedges Pension and Other Postretirement Benefit Plans Foreign Currency Translation Adjustment Accumulated Other Comprehensive (Loss) Income (Dollars in thousands) Balance at December 31, 2014 $ — $ (141,744 ) $ (119,151 ) $ (260,895 ) Other comprehensive loss before reclassifications 243 810 (83,151 ) (82,098 ) Amounts reclassified from accumulated other comprehensive loss (199 ) 1,096 — 897 Net current-period other comprehensive (loss) income 44 1,906 (83,151 ) (81,201 ) Balance at March 29, 2015 $ 44 $ (139,838 ) $ (202,302 ) $ (342,096 ) The following table provides information relating to the reclassifications of losses/(gains) in accumulated other comprehensive (loss) income into expense/(income), net of tax, for the three months ended March 27, 2016 and March 29, 2015 : Three Months Ended March 27, 2016 March 29, 2015 (Dollars in thousands) Losses (gains) on foreign exchange contracts: Cost of goods sold $ 1,871 $ (209 ) Total before tax 1,871 (209 ) Tax (benefit) expense (341 ) 10 Net of tax $ 1,530 $ (199 ) Amortization of pension and other postretirement benefit items: Actuarial losses (1) $ 1,622 $ 1,606 Prior-service costs(1) 14 — Total before tax 1,636 1,606 Tax benefit (580 ) (510 ) Net of tax $ 1,056 $ 1,096 Total reclassifications, net of tax $ 2,586 $ 897 (1) These accumulated other comprehensive (loss) income components are included in the computation of net benefit cost of pension and other postretirement benefit plans (see Note 11 for additional information).

Taxes on income from continuing

Taxes on income from continuing operations	3 Months Ended
	Mar. 27, 2016
Income Tax Disclosure [Abstract]
Taxes on income from continuing operations	Taxes on income from continuing operations Three Months Ended March 27, 2016 March 29, 2015 Effective income tax rate 4.9% 19.2% The effective income tax rate for the three months ended March 27, 2016 and March 29, 2015 was 4.9% and 19.2% , respectively. The decrease in the effective income tax rate for the three months ended March 27, 2016 is primarily due to a tax benefit realized on the settlement of a foreign tax audit as well as a tax benefit associated with a reduction in the estimated deferred tax with respect to non-permanently reinvested income due to an increase in the estimated foreign tax credits available to reduce the U.S. tax on a future repatriation.

Pension and other postretiremen

Pension and other postretirement benefits	3 Months Ended
	Mar. 27, 2016
Compensation and Retirement Disclosure [Abstract]
Pension and other postretirement benefits	Pension and other postretirement benefits The Company has a number of defined benefit pension and postretirement plans covering eligible U.S. and non-U.S. employees. The defined benefit pension plans are noncontributory. The benefits under these plans are based primarily on years of service and employees’ pay near retirement. The Company’s funding policy for U.S. plans is to contribute annually, at a minimum, amounts required by applicable laws and regulations. Obligations under non-U.S. plans are systematically provided for by depositing funds with trustees or by book reserves. As of March 27, 2016 , no further benefits are being accrued under the Company’s U.S. defined benefit pension plans and the Company’s other postretirement benefit plans, other than certain postretirement benefit plans covering employees subject to a collective bargaining agreement. The Company and certain of its subsidiaries provide medical, dental and life insurance benefits to pensioners or their survivors. The associated plans are unfunded and approved claims are paid from Company funds. The following table provides summarized information regarding net benefits expense (income), measured as of March 27, 2016 and March 29, 2015: Pension Other Postretirement Benefits March 27, 2016 March 29, 2015 March 27, 2016 March 29, 2015 (Dollars in thousands) Service cost $ 652 $ 471 $ 111 $ 107 Interest cost 3,920 4,486 406 512 Expected return on plan assets (6,198 ) (6,425 ) — — Net amortization and deferral 1,579 1,530 57 77 Net benefits expense (income) $ (47 ) $ 62 $ 574 $ 696 The Company’s pension contributions are expected to be approximately $2.4 million during 2016, of which $1.1 million was contributed during the three months ended March 27, 2016 .

Commitments and contingent liab

Commitments and contingent liabilities	3 Months Ended
	Mar. 27, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingent liabilities	Commitments and contingent liabilities Operating leases: The Company uses various leased facilities and equipment in its operations. During the first quarter 2016, the Company entered into a build-to-suit lease arrangement for its European and global operations headquarters. For accounting purposes, the Company is deemed the owner of the asset during the construction period and is required to record the estimated fair value of the incurred construction costs as construction in progress, and a current liability for those costs not funded by the Company, during the construction period. The construction of the building and tenant improvements, of which the estimated cost is $16.4 million , is expected to be completed in October 2016. The Company will occupy the entire European headquarters building once construction is completed. As of March 27, 2016, the Company recorded $5.5 million in property, plant and equipment representing the estimated fair value of the construction costs incurred to date. Based on current expectations, the Company believes it is not subject to any continuing involvement requirements that would prohibit the Company from derecognizing the asset and related liability upon commencement of the lease term. Environmental: The Company is subject to contingencies as a result of environmental laws and regulations that in the future may require the Company to take further action to correct the effects on the environment of prior disposal practices or releases of chemical or petroleum substances by the Company or other parties. Much of this liability results from the U.S. Comprehensive Environmental Response, Compensation and Liability Act, often referred to as Superfund, the U.S. Resource Conservation and Recovery Act and similar state laws. These laws require the Company to undertake certain investigative and remedial activities at sites where the Company conducts or once conducted operations or at sites where Company-generated waste was disposed. Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, the regulatory agencies involved and their enforcement policies, as well as the presence or absence of other potentially responsible parties. At March 27, 2016 the Company has recorded $1.2 million and $6.1 million , in accrued liabilities and other liabilities, respectively, relating to these matters. Considerable uncertainty exists with respect to these liabilities and, if adverse changes in circumstances occur, the potential liability may exceed the amount accrued as of March 27, 2016 . The time frame over which the accrued amounts may be paid out, based on past history, is estimated to be 15 - 20 years. Litigation: The Company is a party to various lawsuits and claims arising in the normal course of business. These lawsuits and claims include actions involving product liability, intellectual property, employment, environmental and other matters. As of March 27, 2016 , the Company has recorded accrued liabilities of $2.7 million in connection with such contingencies, representing its best estimate of the cost within the range of estimated possible losses that will be incurred to resolve these matters. Of the amount accrued as of March 27, 2016 , $1.5 million pertains to discontinued operations. In 2006, the Company was named as a defendant in a wrongful death product liability lawsuit filed in the Louisiana State District Court for the Parish of Calcasieu, involving a product manufactured by the Company’s former marine business. In September 2014, the case was tried before a jury, which returned a verdict in favor of the Company. The plaintiff subsequently filed a motion for a new trial, which was granted, and the case was re-tried before a jury in December 2014. On December 5, 2014, the jury returned a verdict in favor of the plaintiff, awarding $0.1 million in compensatory damages and $23.0 million in punitive damages, plus pre- and post-judgment interest on the compensatory damages and post-judgment interest on the punitive damages. The Company's post-trial motions seeking to overturn the verdict or reduce the amount of damages were denied in June 2015. The Company has appealed to the Louisiana Court of Appeal. The plaintiff has filed a cross-appeal, seeking to overturn the trial court’s denial of pre-judgment interest on the punitive damages award. As of March 27, 2016 , the Company has accrued a liability representing its best estimate of probable loss associated with this matter, which is included in the Company’s accrued liabilities for litigation matters relating to discontinued operations discussed in the preceding paragraph. The Company believes that any liability arising from this matter in excess of $10.0 million will be covered by the Company’s product liability insurance. Based on information currently available, advice of counsel, established reserves and other resources, the Company does not believe that the outcome of any outstanding litigation and claims is likely to be, individually or in the aggregate, material to its business, financial condition, results of operations or liquidity. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to the Company’s business, financial condition, results of operations or liquidity. Legal costs such as outside counsel fees and expenses are charged to selling, general and administrative expenses in the period incurred. Tax audits and examinations: The Company and its subsidiaries are routinely subject to tax examinations by various tax authorities. As of March 27, 2016 , the most significant tax examinations in process are in Austria and Canada. The Company may establish reserves with respect to its uncertain tax positions, after which it adjusts its reserves to address developments with respect to these uncertain tax positions. Accordingly, developments in tax audits and examinations, including resolution of uncertain tax positions, could result in increases or decreases to the Company’s recorded tax liabilities, which could impact the Company’s financial results. Other: The Company has various purchase commitments for materials, supplies and items of permanent investment incident to the ordinary conduct of its business. On average, such commitments are not at prices in excess of current market prices.

Segment information

Segment information	3 Months Ended
	Mar. 27, 2016
Segment Reporting [Abstract]
Segment information	Segment information An operating segment is a component of the Company (a) that engages in business activities from which it may earn revenues and incur expenses, (b) whose operating results are regularly reviewed by the Company’s chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance, and (c) for which discrete financial information is available. The Company does not evaluate its operating segments using discrete asset information. Effective April 1, 2015, the Company reorganized certain of its businesses to better leverage the Company’s resources. As a result, the Company realigned its operating segments. Specifically, the Company's Anesthesia/Respiratory North America operating segment was divided into two operating segments, Anesthesia North America and Respiratory North America. Additionally, the businesses comprising the Company's former Specialty operating segment (which was not a reportable segment and, therefore, was included in the "All other" category in the Company's presentation of segment information) were transferred to the Anesthesia North America, Vascular North America and Respiratory North America operating segments. As a result of the operating segment changes described above, the Company has the following six reportable operating segments: Vascular North America, Anesthesia North America, Surgical North America, EMEA, Asia and OEM. In connection with the presentation of segment information, the Company will continue to present certain operating segments, which, effective April 1, 2015, include, among others, the Respiratory North America operating segment, in the “All other” category. All prior comparative periods presented in this report have been restated to reflect these changes. The Company’s reportable segments, other than the Original Equipment Manufacturer and Development Services ("OEM") segment, design, manufacture and distribute medical devices primarily used in critical care, surgical applications and cardiac care and generally serve two end markets: hospitals and healthcare providers, and home health. The products of these segments are most widely used in the acute care setting for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications. The Company’s OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The following tables present the Company’s segment results for the three months ended March 27, 2016 and March 29, 2015 : Three Months Ended March 27, 2016 March 29, 2015 (Dollars in thousands) Revenue Vascular North America $ 81,588 $ 80,766 Anesthesia North America 45,957 45,449 Surgical North America 38,941 38,059 EMEA 122,095 129,282 Asia 49,156 48,529 OEM 33,977 34,715 All other 53,179 52,630 Consolidated net revenues $ 424,893 $ 429,430 Three Months Ended March 27, 2016 March 29, 2015 (Dollars in thousands) Operating profit Vascular North America $ 19,656 $ 15,750 Anesthesia North America 12,177 9,960 Surgical North America 13,256 12,327 EMEA 21,043 26,335 Asia 13,008 8,146 OEM 5,189 8,043 All other 5,743 3,093 Total segment operating profit (1) 90,072 83,654 Unallocated expenses (2) (22,575 ) (18,046 ) Income from continuing operations before interest and taxes $ 67,497 $ 65,608 (1) Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved. (2) Unallocated expenses primarily include manufacturing variances, with the exception of fixed manufacturing cost absorption variances, restructuring charges and gain on sale of assets.

Condensed consolidating guarant

Condensed consolidating guarantor financial information	3 Months Ended
	Mar. 27, 2016
Condensed Consolidated Guarantor Financial Information [Abstract]
Condensed consolidating guarantor financial information	Condensed consolidating guarantor financial information In April 2015, pursuant to an exchange offer registered under the Securities Act of 1933, Teleflex Incorporated (referred to below as “Parent Company”) exchanged $250 million of its 5.25% Senior Notes due 2024 for a like principal amount of substantially identical notes that it issued in a private placement in May 2014. The notes are guaranteed, jointly and severally, by certain of the Parent Company’s subsidiaries (each, a “Guarantor Subsidiary” and collectively, the “Guarantor Subsidiaries”). The guarantees are full and unconditional, subject to certain customary release provisions. Each Guarantor Subsidiary is directly or indirectly 100% owned by the Parent Company. The Company’s condensed consolidating statements of income and comprehensive income (loss) for the three months ended March 27, 2016 and March 29, 2015 , condensed consolidating balance sheets as of March 27, 2016 and December 31, 2015 and condensed consolidating statements of cash flows for the three months ended March 27, 2016 and March 29, 2015 , provide consolidated information for: a. Parent Company, the issuer of the guaranteed obligations; b. Guarantor Subsidiaries, on a combined basis; c. Non-Guarantor Subsidiaries, on a combined basis; and d. Parent Company and its subsidiaries on a consolidated basis. The same accounting policies as described in Note 1 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 are used by the Parent Company and each of its subsidiaries in connection with the condensed consolidating financial information, except for the use by the Parent Company and Guarantor Subsidiaries of the equity method of accounting to reflect ownership interests in subsidiaries which are eliminated upon consolidation. Consolidating entries and eliminations in the following condensed consolidated financial statements represent adjustments to (a) eliminate intercompany transactions between or among the Parent Company, the Guarantor Subsidiaries and the Non-Guarantor Subsidiaries, (b) eliminate the investments in subsidiaries and (c) record consolidating entries. The Company made revisions to the classification of certain balances related to intercompany transactions in the condensed consolidating statements of income and comprehensive loss for the three months ended March 29, 2015, as well as the condensed consolidating statement of cash flows for the three months ended March 29, 2015 . These revisions, individually and in the aggregate, had no impact on the consolidated results of the Company and are not material to the condensed consolidating guarantor financial information for any of the periods subject to previously filed condensed consolidating guarantor financial information. TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) Three Months Ended March 27, 2016 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net revenues $ — $ 258,911 $ 261,348 $ (95,366 ) $ 424,893 Cost of goods sold — 155,541 132,963 (88,758 ) 199,746 Gross profit — 103,370 128,385 (6,608 ) 225,147 Selling, general and administrative expenses 9,329 81,477 45,059 483 136,348 Research and development expenses — 6,435 5,918 — 12,353 Restructuring charges — 4,758 5,210 — 9,968 Gain on sale of assets — — (1,019 ) — (1,019 ) (Loss) income from continuing operations before interest and taxes (9,329 ) 10,700 73,217 (7,091 ) 67,497 Interest, net 33,044 (20,318 ) 978 — 13,704 (Loss) income from continuing operations before taxes (42,373 ) 31,018 72,239 (7,091 ) 53,793 (Benefit) taxes on income from continuing operations (15,848 ) 11,677 7,864 (1,080 ) 2,613 Equity in net income of consolidated subsidiaries 77,457 57,900 168 (135,525 ) — Income from continuing operations 50,932 77,241 64,543 (141,536 ) 51,180 Operating loss from discontinued operations (382 ) — — — (382 ) (Benefit) taxes on loss from discontinued operations (139 ) — 69 — (70 ) Loss from discontinued operations (243 ) — (69 ) — (312 ) Net income 50,689 77,241 64,474 (141,536 ) 50,868 Less: Income from continuing operations attributable to noncontrolling interest — — 179 — 179 Net income attributable to common shareholders 50,689 77,241 64,295 (141,536 ) 50,689 Other comprehensive income attributable to common shareholders 23,194 18,573 22,412 (40,985 ) 23,194 Comprehensive income attributable to common shareholders $ 73,883 $ 95,814 $ 86,707 $ (182,521 ) $ 73,883 Three Months Ended March 29, 2015 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net revenues $ — $ 264,161 $ 258,901 $ (93,632 ) $ 429,430 Cost of goods sold — 158,326 137,618 (89,151 ) 206,793 Gross profit — 105,835 121,283 (4,481 ) 222,637 Selling, general and administrative expenses 11,452 84,268 43,817 160 139,697 Research and development expenses — 11,127 1,757 — 12,884 Restructuring charges — 3,739 709 — 4,448 (Loss) income from continuing operations before interest and taxes (11,452 ) 6,701 75,000 (4,641 ) 65,608 Interest, net 34,360 (18,569 ) 1,212 — 17,003 (Loss) income from continuing operations before taxes (45,812 ) 25,270 73,788 (4,641 ) 48,605 (Benefit) taxes on (loss) income from continuing operations (15,293 ) 10,992 14,744 (1,111 ) 9,332 Equity in net income of consolidated subsidiaries 69,538 59,690 97 (129,325 ) — Income from continuing operations 39,019 73,968 59,141 (132,855 ) 39,273 Operating (loss) income from discontinued operations (503 ) — 4 — (499 ) Taxes on loss from discontinued operations 164 — 40 — 204 Loss from discontinued operations (667 ) — (36 ) — (703 ) Net income 38,352 73,968 59,105 (132,855 ) 38,570 Less: Income from continuing operations attributable to noncontrolling interest — — 218 — 218 Net income attributable to common shareholders 38,352 73,968 58,887 (132,855 ) 38,352 Other comprehensive loss attributable to common shareholders (81,201 ) (106,761 ) (99,728 ) 206,489 (81,201 ) Comprehensive loss attributable to common shareholders $ (42,849 ) $ (32,793 ) $ (40,841 ) $ 73,634 $ (42,849 ) TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING BALANCE SHEETS March 27, 2016 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) ASSETS Current assets Cash and cash equivalents $ 23,992 $ 1,005 $ 367,561 $ — $ 392,558 Accounts receivable, net 2,688 3,969 264,101 3,902 274,660 Accounts receivable from consolidated subsidiaries 4,691 2,408,849 315,430 (2,728,970 ) — Inventories, net — 207,361 162,803 (31,258 ) 338,906 Prepaid expenses and other current assets 12,505 7,136 17,427 3,665 40,733 Prepaid taxes 11,045 — 20,053 — 31,098 Assets held for sale 2,901 — 4,153 — 7,054 Total current assets 57,822 2,628,320 1,151,528 (2,752,661 ) 1,085,009 Property, plant and equipment, net 2,817 170,273 145,093 — 318,183 Goodwill — 705,754 597,702 — 1,303,456 Intangibles assets, net — 752,114 436,739 — 1,188,853 Investments in affiliates 5,823,852 1,436,790 23,143 (7,283,589 ) 196 Deferred tax assets 85,243 — 6,731 (89,616 ) 2,358 Notes receivable and other amounts due from consolidated subsidiaries 1,339,835 1,688,217 — (3,028,052 ) — Other assets 22,697 6,647 16,067 — 45,411 Total assets $ 7,332,266 $ 7,388,115 $ 2,377,003 $ (13,153,918 ) $ 3,943,466 LIABILITIES AND EQUITY Current liabilities Current borrowings $ 377,898 $ — $ 43,300 $ — $ 421,198 Accounts payable 3,403 32,514 37,396 — 73,313 Accounts payable to consolidated subsidiaries 2,461,194 227,846 39,930 (2,728,970 ) — Accrued expenses 15,623 20,429 32,745 — 68,797 Current portion of contingent consideration — 7,397 — — 7,397 Payroll and benefit-related liabilities 16,749 16,724 38,558 — 72,031 Accrued interest 6,615 — 20 — 6,635 Income taxes payable — — 13,452 (752 ) 12,700 Other current liabilities 1,968 2,623 8,013 — 12,604 Total current liabilities 2,883,450 307,533 213,414 (2,729,722 ) 674,675 Long-term borrowings 641,973 — — — 641,973 Deferred tax liabilities — 376,062 35,597 (89,616 ) 322,043 Pension and other postretirement benefit liabilities 98,086 32,000 16,718 — 146,804 Noncurrent liability for uncertain tax positions 1,321 17,775 7,072 — 26,168 Notes payable and other amounts due to consolidated subsidiaries 1,612,032 1,229,786 186,234 (3,028,052 ) — Other liabilities 23,308 21,764 12,656 — 57,728 Total liabilities 5,260,170 1,984,920 471,691 (5,847,390 ) 1,869,391 Convertible notes - redeemable equity component 12,877 — — — 12,877 Mezzanine equity 12,877 — — — 12,877 Total common shareholders' equity 2,059,219 5,403,195 1,903,333 (7,306,528 ) 2,059,219 Noncontrolling interest — — 1,979 — 1,979 Total equity 2,059,219 5,403,195 1,905,312 (7,306,528 ) 2,061,198 Total liabilities and equity $ 7,332,266 $ 7,388,115 $ 2,377,003 $ (13,153,918 ) $ 3,943,466 December 31, 2015 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) ASSETS Current assets Cash and cash equivalents $ 21,612 $ — $ 316,754 $ — $ 338,366 Accounts receivable, net 2,538 4,326 251,166 4,386 262,416 Accounts receivable from consolidated subsidiaries 5,276 2,412,079 289,697 (2,707,052 ) — Inventories, net — 205,163 149,705 (24,593 ) 330,275 Prepaid expenses and other current assets 10,511 4,702 16,037 3,665 34,915 Prepaid taxes 16,686 — 14,622 (413 ) 30,895 Assets held for sale 2,901 — 4,071 — 6,972 Total current assets 59,524 2,626,270 1,042,052 (2,724,007 ) 1,003,839 Property, plant and equipment, net 2,931 174,674 138,518 — 316,123 Goodwill — 705,753 590,099 — 1,295,852 Intangibles assets, net — 762,084 437,891 — 1,199,975 Investments in affiliates 5,724,226 1,360,045 23,065 (7,107,184 ) 152 Deferred tax assets 91,432 — 8,042 (97,133 ) 2,341 Notes receivable and other amounts due from consolidated subsidiaries 1,358,446 1,658,092 — (3,016,538 ) — Other assets 22,602 6,615 24,275 — 53,492 Total assets $ 7,259,161 $ 7,293,533 $ 2,263,942 $ (12,944,862 ) $ 3,871,774 LIABILITIES AND EQUITY Current liabilities Current borrowings $ 374,050 $ — $ 43,300 $ — $ 417,350 Accounts payable 1,945 27,527 36,833 — 66,305 Accounts payable to consolidated subsidiaries 2,478,109 201,400 27,543 (2,707,052 ) — Accrued expenses 15,399 22,281 26,337 — 64,017 Current portion of contingent consideration — 7,291 — — 7,291 Payroll and benefit-related liabilities 21,617 29,305 33,736 — 84,658 Accrued interest 7,455 — 25 — 7,480 Income taxes payable — — 8,144 (85 ) 8,059 Other current liabilities 1,300 2,679 4,981 — 8,960 Total current liabilities 2,899,875 290,483 180,899 (2,707,137 ) 664,120 Long-term borrowings 641,850 — — — 641,850 Deferred tax liabilities — 376,738 36,378 (97,133 ) 315,983 Pension and other postretirement benefit liabilities 100,355 32,274 16,812 — 149,441 Noncurrent liability for uncertain tax positions 1,151 17,722 21,527 — 40,400 Notes payable and other amounts due to consolidated subsidiaries 1,585,727 1,253,189 177,622 (3,016,538 ) — Other liabilities 20,931 15,685 12,271 — 48,887 Total liabilities 5,249,889 1,986,091 445,509 (5,820,808 ) 1,860,681 Total common shareholders' equity 2,009,272 5,307,442 1,816,612 (7,124,054 ) 2,009,272 Noncontrolling interest — — 1,821 — 1,821 Total equity 2,009,272 5,307,442 1,818,433 (7,124,054 ) 2,011,093 Total liabilities and equity $ 7,259,161 $ 7,293,533 $ 2,263,942 $ (12,944,862 ) $ 3,871,774 TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Three Months Ended March 27, 2016 Parent Guarantor Non-Guarantor Condensed (Dollars in thousands) Net cash (used in) provided by operating activities from continuing operations $ (18,852 ) $ 25,624 $ 60,060 $ 66,832 Cash flows from investing activities of continuing operations: Expenditures for property, plant and equipment (5 ) (3,470 ) (4,347 ) (7,822 ) Proceeds from sale of assets — — 1,251 1,251 Net cash used in investing activities from continuing operations (5 ) (3,470 ) (3,096 ) (6,571 ) Cash flows from financing activities of continuing operations: Reduction in borrowings (9 ) — — (9 ) Net proceeds from share based compensation plans and the related tax impacts 3,180 — — 3,180 Payments for contingent consideration — (61 ) — (61 ) Dividends paid (14,179 ) — — (14,179 ) Intercompany transactions 32,371 (21,088 ) (11,283 ) — Net cash provided by (used in) financing activities from continuing operations 21,363 (21,149 ) (11,283 ) (11,069 ) Cash flows from discontinued operations: Net cash used in operating activities (126 ) — — (126 ) Net cash used in discontinued operations (126 ) — — (126 ) Effect of exchange rate changes on cash and cash equivalents — — 5,126 5,126 Net increase in cash and cash equivalents 2,380 1,005 50,807 54,192 Cash and cash equivalents at the beginning of the period 21,612 — 316,754 338,366 Cash and cash equivalents at the end of the period $ 23,992 $ 1,005 $ 367,561 $ 392,558 Three Months Ended March 29, 2015 Parent Guarantor Non-Guarantor Condensed (Dollars in thousands) Net cash (used in) provided by operating activities from continuing operations $ (55,161 ) $ 21,527 $ 75,992 $ 42,358 Cash flows from investing activities of continuing operations: Expenditures for property, plant and equipment (37 ) (7,738 ) (6,670 ) (14,445 ) Payments for businesses and intangibles acquired, net of cash acquired — — (7,375 ) (7,375 ) Net cash used in investing activities from continuing operations (37 ) (7,738 ) (14,045 ) (21,820 ) Cash flows from financing activities of continuing operations: Proceeds from new borrowings 30,000 — — 30,000 Reduction in borrowings (52 ) — — (52 ) Net proceeds from share based compensation plans and the related tax impacts (289 ) — — (289 ) Payments for contingent consideration (3,989 ) (3,989 ) Dividends paid (14,118 ) — — (14,118 ) Intercompany transactions 40,065 (9,800 ) (30,265 ) — Net cash provided by (used in) financing activities from continuing operations 55,606 (13,789 ) (30,265 ) 11,552 Cash flows from discontinued operations: Net cash used in operating activities (302 ) — (824 ) (1,126 ) Net cash used in discontinued operations (302 ) — (824 ) (1,126 ) Effect of exchange rate changes on cash and cash equivalents — — (25,441 ) (25,441 ) Net increase in cash and cash equivalents 106 — 5,417 5,523 Cash and cash equivalents at the beginning of the period 27,996 — 275,240 303,236 Cash and cash equivalents at the end of the period $ 28,102 $ — $ 280,657 $ 308,759

Subsequent event

Subsequent event	3 Months Ended
	Mar. 27, 2016
Subsequent Events [Abstract]
Subsequent event	Subsequent event On April 4, 2016, pursuant to separate, privately negotiated agreements between the Company and certain of the holders of the Convertible Notes (the "Holders"), the Company paid cash and common stock (the "Exchange Consideration") to the Holders in exchange for $219.2 million aggregate principal amount of the Convertible Notes (the "Exchange Transactions"). The Exchange Consideration paid to the Holders per $1,000 principal amount of Convertible Notes is equal to: (i) $1,000 in cash, (ii) a number of shares of the Company’s common stock equal to the amount of the conversion value of the Convertible Notes in excess of the $1,000 principal amount (the "Conversion Shares") calculated on the basis of the average daily volume weighted average price (the "Average Daily VWAP") per share of Company common stock over a specified period , (iii) an inducement payment in additional shares of common stock (the "Inducement Shares"), calculated based on the Average Daily VWAP and (iv) cash in an amount equal to accrued and unpaid interest to, but not including, the closing date. As a result of the Exchange Transactions, the Company paid the Holders aggregate cash consideration of $220.7 million (which includes $1.5 million in accrued but previously unpaid interest) and issued and delivered to the Holders 2.17 million shares of Company common stock (including both Conversion Shares and Inducement Shares).The Company funded the $220.7 million cash payment constituting part of the Exchange Consideration through borrowings under its revolving credit agreement. Following the Exchange Transactions, and after giving effect to the conversion notices the Company has received, but not yet settled, through March 27, 2016 with respect to $44.3 million in aggregate principal amount of the Convertible Notes, $136.2 million aggregate principal amount of the Convertible Notes were outstanding. The issuance of the shares of the Company’s common stock to the Holders pursuant to the Exchange Transactions was made pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), under Section 3(a)(9) of the Securities Act. As of March 27, 2016, the Company reclassified $12.9 million from additional paid-in capital to convertible notes in the mezzanine equity section of the Company's condensed consolidated balance sheet. The reclassified amount represents the aggregate difference between the principal amount and the carrying value of both the Convertible Notes purchased by the Company pursuant to the Exchange Transactions and the Convertible Notes for which conversion notices have been received by the Company but have not yet been settled . In addition, as a result of the Exchange Transactions, the Company recognized a loss on extinguishment of debt of $16.3 million in April 2016. In connection with entering into the Exchange Transactions, the Company also entered into bond hedge unwind agreements (the "Hedge Unwind Agreements") with the counterparties to the convertible note hedge transactions related to the Convertible Notes. Under the Hedge Unwind Agreements, the number of call options subject to the Convertible Note hedge transactions was reduced to reflect proportionately the reduction in the outstanding principal amount of the Convertible Notes following the Exchange Transactions. In addition, the Company entered into warrant unwind agreements (the “Warrant Unwind Agreements”) with the dealer counterparties to reduce the number of warrants initially issued to the dealer counterparties, also in connection with the initial issuance of the Convertible Notes. On a net basis, after giving effect to the Hedge Unwind Agreements and Warrant Unwind Agreements, the Company received 0.3 million shares of Company common stock from such dealer counterparties.

New accounting standards (Polic

New accounting standards (Policies)	3 Months Ended
	Mar. 27, 2016
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
New accounting standards	New accounting standards In May 2014, the Financial Accounting Standards Board ("FASB"), in a joint effort with the International Accounting Standards Board ("IASB"), issued new accounting guidance to clarify the principles for recognizing revenue. The new guidance is designed to enhance the comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, and will affect any entity that enters into contracts with customers or enters into contracts for the transfer of nonfinancial assets, unless those contracts are within the scope of other standards. The new guidance establishes principles for reporting information to users of financial statements about the nature, amount, timing, and uncertainty of revenue and cash flows arising from an entity's contracts with customers. The core principle of the new guidance is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued an amendment to the new guidance that defers the effective date. The amendment provides that the new guidance is effective prospectively for annual periods beginning after December 15, 2017 and interim periods within those years; early application is permitted for annual periods beginning after December 15, 2016. The Company is currently evaluating this guidance to determine its impact on the Company’s results of operations, cash flows and financial position. In April 2015, the FASB issued guidance for the reporting of debt issuance costs within the balance sheet. Under the new guidance, debt issuance costs related to term loans are to be presented in the balance sheet as a direct deduction from the associated debt liability, consistent with the presentation of a debt discount. Previously, debt issuance costs were presented as a deferred charge (i.e., an asset) on the balance sheet. The guidance provides uniform treatment for debt issuance costs and debt discounts and eliminates inconsistencies that previously existed with other FASB guidance. The Company retrospectively adopted this guidance as of January 1, 2016. In February 2016, the FASB issued guidance that will change the requirements for accounting for leases. The principal change under the new accounting guidance is that lessees under leases classified as operating leases will recognize a right-of-use asset and a lease liability. Current lease accounting does not require lessees to recognize assets and liabilities arising under operating leases on the balance sheet. Under the new guidance, lessees (including lessees under leases classified as finance leases and operating leases) will recognize a right-to-use asset and a lease liability on the balance sheet, initially measured as the present value of lease payments under the lease. Expense recognition and cash flow presentation guidance will be based upon whether the lease is classified as an operating lease or a finance lease (the classification criteria for distinguishing between finance leases and operating leases is substantially similar to the classification criteria for distinguishing between capital leases and operating leases under current guidance). The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition approach for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements; the guidance provides certain practical expedients. The Company is currently evaluating this guidance to determine its impact on the Company’s results of operations, cash flows and financial position. In March 2016, the FASB issued new guidance designed to simplify several aspects of the accounting for share-based payment transactions, including guidance relating to accounting for income taxes with respect to share-based payment awards; providing generally that excess tax benefits related to share-based awards should be recorded as a reduction to income tax expense (currently, excess tax benefits generally are recorded to additional-paid-in-capital); providing generally that excess tax benefits related to share-based awards should be classified along with other income tax cash flows as an operating activity (currently, excess tax benefits generally are separated from other income tax cash flows and classified as a financing activity); providing that an entity may make an accounting policy election either to base compensation cost accruals on the number of awards expected to vest (as required by current guidance) or to account for forfeitures when they occur; modifying the current exception to liability classification such that partial cash settlement of an award for tax withholding purposes would not result, by itself, in liability classification of the award if the amount withheld does not exceed the maximum statutory tax rate in the employees' applicable jurisdictions (currently, an award cannot qualify for equity classification, rather than liability classification, if the amount withheld exceeds the minimum statutory withholding requirements); and providing that cash paid by an employer when directly withholding shares for tax withholding purposes should be classified as a financing activity on the statement of cash flows (currently there is no authoritative guidance addressing this classification issue). The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted (if early adoption occurs in an interim period, any adjustments will be reflected as of the beginning of the fiscal year that includes the interim period). Depending on the particular issue addressed by the guidance, application of the guidance will be made prospectively, retrospectively or subject to a retrospective transition method. We are currently evaluating the potential impact of adopting this guidance on the Company's results of operations, cash flows and financial position. From time to time, new accounting guidance is issued by the FASB or other standard setting bodies that is adopted by the Company as of the effective date or, in some cases where early adoption is permitted, in advance of the effective date. The Company has assessed the recently issued guidance that is not yet effective and, unless otherwise indicated above, believes the new guidance will not have a material impact on the Company’s results of operations, cash flows or financial position.

Restructuring charges (Tables)

Restructuring charges (Tables)	3 Months Ended
	Mar. 27, 2016
Restructuring and Related Activities [Abstract]
Summary of Current Cost Estimates by Major Type of Cost Associated with 2014 Manufacturing Footprint Realignment Plan	The following table provides a summary of the Company's current cost estimates for each major expense category associated with the 2016 Plan: Type of expense Total estimated amount expected to be incurred Employee termination benefits $14 million to $18 million Facility closure and other exit costs (1) $2 million to $3 million Accelerated depreciation charges $10 million to $13 million Other (2) $8 million to $10 million $34 million to $44 million (1) Includes costs to transfer product lines among facilities, legal, outplacement and employee relocation costs. (2) Consists of other costs directly related to the 2016 Plan, including project management and other regulatory costs.
Restructuring and Other Impairment Charges	The restructuring charges recognized for the three months ended March 27, 2016 and March 29, 2015 consisted of the following: Three Months Ended March 27, 2016 (in thousands) Termination Benefits Facility Contract Termination Costs Other Exit Costs Total 2016 Manufacturing footprint realignment plan $ 10,347 $ — $ — $ — $ 10,347 2015 Restructuring programs 43 123 (22 ) 93 237 2014 Manufacturing footprint realignment plan (538 ) — — 2 (536 ) Other restructuring programs - prior years (1) — — (86 ) 6 (80 ) Total restructuring charges $ 9,852 $ 123 $ (108 ) $ 101 $ 9,968 Three Months Ended March 29, 2015 (in thousands) Termination Benefits Facility Closure Costs Contract Termination Costs Other Exit Costs Total 2015 Restructuring programs $ 3,550 $ 67 $ 621 $ — $ 4,238 2014 Manufacturing footprint realignment plan 137 22 — 4 163 Other restructuring programs - prior years (1) 12 — 18 17 47 Total restructuring charges $ 3,699 $ 89 $ 639 21 $ 4,448 (1) Other restructuring programs - prior years includes the 2014 European Restructuring Plan, the Other 2014 restructuring programs, the 2013 Restructuring programs and the LMA restructuring program. For a description of these plans, see Note 4 to the Company’s consolidated financial statements included in its annual report on Form 10-K for the year ended December 31, 2015. Restructuring charges by reportable operating segment for the three months ended March 27, 2016 and March 29, 2015 are set forth in the following table: Three Months Ended March 27, 2016 March 29, 2015 (Dollars in thousands) Restructuring charges Vascular North America $ 4,163 $ 2,263 Anesthesia North America 1,875 537 Surgical North America (19 ) 23 EMEA 3,872 (32 ) Asia 2 — OEM 4 — All other 71 1,657 Total restructuring charges $ 9,968 $ 4,448

Inventories, net (Tables)

Inventories, net (Tables)	3 Months Ended
	Mar. 27, 2016
Inventory Disclosure [Abstract]
Inventories, net	Inventories as of March 27, 2016 and December 31, 2015 consisted of the following: March 27, 2016 December 31, 2015 (Dollars in thousands) Raw materials $ 79,405 $ 76,037 Work-in-process 58,729 60,218 Finished goods 237,661 230,536 375,795 366,791 Less: inventory reserve (36,889 ) (36,516 ) Inventories, net $ 338,906 $ 330,275

Goodwill and other intangible27

Goodwill and other intangible assets, net (Tables)	3 Months Ended
	Mar. 27, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in Carrying Amount of Goodwill, by Reporting Segment	The following table provides information relating to changes in the carrying amount of goodwill by reportable segment for the three months ended March 27, 2016 : Vascular Anesthesia Surgical EMEA Asia OEM All Total (Dollars in thousands) Balance as of December 31, 2015 $ 345,546 $ 141,122 $ 250,912 $ 306,009 $ 141,067 $ 1,194 $ 110,002 $ 1,295,852 Currency translation adjustment — 349 — 2,848 4,624 — (217 ) 7,604 Balance as of March 27, 2016 $ 345,546 $ 141,471 $ 250,912 $ 308,857 $ 145,691 $ 1,194 $ 109,785 $ 1,303,456
Components of Intangible Assets	The following table provides information as of March 27, 2016 and December 31, 2015 regarding the gross carrying amount of, and accumulated amortization relating to, intangible assets, net: Gross Carrying Amount Accumulated Amortization March 27, 2016 December 31, 2015 March 27, 2016 December 31, 2015 (Dollars in thousands) Customer relationships $ 623,151 $ 621,078 $ (222,109 ) $ (214,924 ) In-process research and development 58,908 58,908 — — Intellectual property 523,287 522,374 (181,482 ) (173,903 ) Distribution rights 23,376 23,279 (14,767 ) (14,393 ) Trade names 387,088 384,821 (10,202 ) (8,929 ) Non-compete agreements 2,223 2,186 (620 ) (522 ) $ 1,618,033 $ 1,612,646 $ (429,180 ) $ (412,671 )

Borrowings (Tables)

Borrowings (Tables)	3 Months Ended
	Mar. 27, 2016
Debt Disclosure [Abstract]
Components of Long-Term Debt	The Company's borrowings at March 27, 2016 and December 31, 2015 are as follows: March 27, 2016 December 31, 2015 (Dollars in thousands) Senior Credit Facility: Revolving credit facility, at a rate of 2.02% at March 27, 2016, due 2018 $ 396,000 $ 396,000 3.875% Convertible Senior Subordinated Notes due 2017 (1) 399,632 399,641 5.25% Senior Notes due 2024 250,000 250,000 Securitization program, at a rate of 1.19% at March 27, 2016 43,300 43,300 1,088,932 1,088,941 Less: Unamortized debt discount on 3.875% Convertible Senior Subordinated Notes due 2017 (19,532 ) (22,999 ) Less: Unamortized debt issuance costs (6,229 ) (6,742 ) 1,063,171 1,059,200 Current borrowings (421,198 ) (417,350 ) Long-term borrowings $ 641,973 $ 641,850 (1) The aggregate outstanding principal amount of the 3.875% Convertible Senior Subordinated Notes due 2017 (the "Convertible Notes") shown in the table above has not been reduced to reflect conversion notices received by the Company in respect of $44.3 million in aggregate principal amount of the Convertible Notes because the conversions were not settled as of March 27, 2016.
Fair Value of Long-Term Debt	The following table provides the fair value of the Company’s debt as of March 27, 2016 and December 31, 2015, categorized by the level of inputs within the fair value hierarchy used to measure fair value (see Note 10, “Fair value measurement,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 for further information): March 27, 2016 December 31, 2015 (Dollars in thousands) Level 1 $ 987,491 $ 858,709 Level 2 695,928 687,072 Total $ 1,683,419 $ 1,545,781

Financial instruments (Tables)

Financial instruments (Tables)	3 Months Ended
	Mar. 27, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Values of Derivative Instruments Designated as Hedging Instruments	The following table presents the location of derivative financial instruments reported in the condensed consolidated balance sheet as of March 27, 2016 and December 31, 2015 : March 27, 2016 December 31, 2015 Fair Value Fair Value (Dollars in thousands) Asset derivatives: Designated foreign currency forward contracts $ 2,252 $ 285 Non-designated foreign currency forward contracts 259 44 Prepaid expenses and other current assets $ 2,511 $ 329 Total asset derivatives $ 2,511 $ 329 Liability derivatives: Designated foreign currency forward contracts $ 1,705 $ 807 Non-designated foreign currency forward contracts 168 491 Other current liabilities $ 1,873 $ 1,298 Total liability derivatives $ 1,873 $ 1,298
After Tax Gain/(Loss) Recognized in OCI	The following table provides information as to the gains and losses attributable to derivatives in cash flow hedging relationships that were reported in other comprehensive income (loss) (“OCI”) for the three months ended March 27, 2016 and March 29, 2015 : After Tax Gain (Loss) Recognized in OCI Three Months Ended March 27, 2016 March 29, 2015 Foreign currency forward contracts $ 1,480 $ 44 Total $ 1,480 $ 44
Aggregate Accounts Receivable, Net of Allowance for Doubtful Accounts	The aggregate net current and long-term accounts receivable for customers in Greece, Italy, Spain and Portugal and the percentage of the Company’s total net current and long-term accounts receivable represented by the net current and long-term accounts receivable for customers in those countries at March 27, 2016 and December 31, 2015 are as follows: March 27, 2016 December 31, 2015 (Dollars in thousands) Current and long-term accounts receivable (net of allowances of $7.3 million and $7.2 million at March 27, 2016 and December 31, 2015, respectively) in Greece, Italy, Spain and Portugal (1) $ 70,343 $ 62,272 Percentage of total net current and long-term accounts receivable - Greece, Italy, Spain and Portugal 25.6 % 23.9 % (1) The long-term portion of accounts receivable, net from customers in Greece, Italy, Spain and Portugal at March 27, 2016 and December 31, 2015 was $9.6 million and $8.1 million , respectively, and is reported on the condensed consolidated balance sheet in other assets.

Fair value measurement (Tables)

Fair value measurement (Tables)	3 Months Ended
	Mar. 27, 2016
Fair Value Disclosures [Abstract]
Financial Assets and Liabilities Carried at Fair Value Measured on Recurring Basis	The following tables provide information regarding the financial assets and liabilities measured at fair value on a recurring basis as of March 27, 2016 and December 31, 2015 : Total carrying Quoted prices in active markets (Level 1) Significant other Significant (Dollars in thousands) Investments in marketable securities $ 7,007 $ 7,007 $ — $ — Derivative assets 2,511 — 2,511 — Derivative liabilities 1,873 — 1,873 — Contingent consideration liabilities 21,145 — — 21,145 Total carrying Quoted prices in active markets (Level 1) Significant other Significant (Dollars in thousands) Investments in marketable securities $ 6,922 $ 6,922 $ — $ — Derivative assets 329 — 329 — Derivative liabilities 1,298 — 1,298 — Contingent consideration liabilities 20,829 — — 20,829
Reconciliation of Changes in Level 3 Financial Liabilities Measured at Fair Value on Recurring Basis	The following table provides information regarding changes, during the three months ended March 27, 2016 , in Level 3 financial liabilities related to contingent consideration in connection with various Company acquisitions: Contingent consideration 2016 (Dollars in thousands) Balance - December 31, 2015 $ 20,829 Payment (61 ) Revaluations 377 Balance - March 27, 2016 $ 21,145
Valuation Technique and Inputs Used to Determine Fair Value of Assets or Liabilities	The following table provides information regarding the valuation techniques and inputs used in determining the fair value of assets or liabilities categorized as Level 3 measurements as of March 27, 2016 : Valuation Technique Unobservable Input Range (Weighted Average) Contingent consideration Discounted cash flow Discount rate 2.6% - 10% (8.3%) Contingent consideration Probability of payment 0% - 100% (52.7%)

Changes in shareholders' equi31

Changes in shareholders' equity (Tables)	3 Months Ended
	Mar. 27, 2016
Equity [Abstract]
Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding	The following table provides a reconciliation of basic to diluted weighted average shares outstanding: Three Months Ended March 27, 2016 March 29, 2015 (Shares in thousands) Basic 41,647 41,469 Dilutive effect of share-based awards 519 467 Dilutive effect of 3.875% Convertible Notes and warrants 6,616 5,359 Diluted 48,782 47,295
Change in Accumulated Other Comprehensive Income (Loss)	The following tables provide information relating to the changes in accumulated other comprehensive loss, net of tax, for the three months ended March 27, 2016 and March 29, 2015 : Cash Flow Hedges Pension and Other Postretirement Benefit Plans Foreign Currency Translation Adjustment Accumulated Other Comprehensive (Loss) Income (Dollars in thousands) Balance as of December 31, 2015 $ (2,491 ) $ (138,887 ) $ (229,746 ) $ (371,124 ) Other comprehensive income (loss) before reclassifications (50 ) 182 20,476 20,608 Amounts reclassified from accumulated other comprehensive (loss) income 1,530 1,056 — 2,586 Net current-period other comprehensive income 1,480 1,238 20,476 23,194 Balance as of March 27, 2016 $ (1,011 ) $ (137,649 ) $ (209,270 ) $ (347,930 ) Cash Flow Hedges Pension and Other Postretirement Benefit Plans Foreign Currency Translation Adjustment Accumulated Other Comprehensive (Loss) Income (Dollars in thousands) Balance at December 31, 2014 $ — $ (141,744 ) $ (119,151 ) $ (260,895 ) Other comprehensive loss before reclassifications 243 810 (83,151 ) (82,098 ) Amounts reclassified from accumulated other comprehensive loss (199 ) 1,096 — 897 Net current-period other comprehensive (loss) income 44 1,906 (83,151 ) (81,201 ) Balance at March 29, 2015 $ 44 $ (139,838 ) $ (202,302 ) $ (342,096 )
Reclassification of Gain/Losses into Income/Expense, Net of Tax	The following table provides information relating to the reclassifications of losses/(gains) in accumulated other comprehensive (loss) income into expense/(income), net of tax, for the three months ended March 27, 2016 and March 29, 2015 : Three Months Ended March 27, 2016 March 29, 2015 (Dollars in thousands) Losses (gains) on foreign exchange contracts: Cost of goods sold $ 1,871 $ (209 ) Total before tax 1,871 (209 ) Tax (benefit) expense (341 ) 10 Net of tax $ 1,530 $ (199 ) Amortization of pension and other postretirement benefit items: Actuarial losses (1) $ 1,622 $ 1,606 Prior-service costs(1) 14 — Total before tax 1,636 1,606 Tax benefit (580 ) (510 ) Net of tax $ 1,056 $ 1,096 Total reclassifications, net of tax $ 2,586 $ 897 (1) These accumulated other comprehensive (loss) income components are included in the computation of net benefit cost of pension and other postretirement benefit plans (see Note 11 for additional information).

Taxes on income from continui32

Taxes on income from continuing operations (Tables)	3 Months Ended
	Mar. 27, 2016
Income Tax Disclosure [Abstract]
Effective Income Tax Rate	Three Months Ended March 27, 2016 March 29, 2015 Effective income tax rate 4.9% 19.2%

Pension and other postretirem33

Pension and other postretirement benefits (Tables)	3 Months Ended
	Mar. 27, 2016
Compensation and Retirement Disclosure [Abstract]
Net Benefit Cost of Pension and Postretirement Benefit Plans	The following table provides summarized information regarding net benefits expense (income), measured as of March 27, 2016 and March 29, 2015: Pension Other Postretirement Benefits March 27, 2016 March 29, 2015 March 27, 2016 March 29, 2015 (Dollars in thousands) Service cost $ 652 $ 471 $ 111 $ 107 Interest cost 3,920 4,486 406 512 Expected return on plan assets (6,198 ) (6,425 ) — — Net amortization and deferral 1,579 1,530 57 77 Net benefits expense (income) $ (47 ) $ 62 $ 574 $ 696

Segment information (Tables)

Segment information (Tables)	3 Months Ended
	Mar. 27, 2016
Segment Reporting [Abstract]
Segment Results	The following tables present the Company’s segment results for the three months ended March 27, 2016 and March 29, 2015 : Three Months Ended March 27, 2016 March 29, 2015 (Dollars in thousands) Revenue Vascular North America $ 81,588 $ 80,766 Anesthesia North America 45,957 45,449 Surgical North America 38,941 38,059 EMEA 122,095 129,282 Asia 49,156 48,529 OEM 33,977 34,715 All other 53,179 52,630 Consolidated net revenues $ 424,893 $ 429,430 Three Months Ended March 27, 2016 March 29, 2015 (Dollars in thousands) Operating profit Vascular North America $ 19,656 $ 15,750 Anesthesia North America 12,177 9,960 Surgical North America 13,256 12,327 EMEA 21,043 26,335 Asia 13,008 8,146 OEM 5,189 8,043 All other 5,743 3,093 Total segment operating profit (1) 90,072 83,654 Unallocated expenses (2) (22,575 ) (18,046 ) Income from continuing operations before interest and taxes $ 67,497 $ 65,608 (1) Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved. (2) Unallocated expenses primarily include manufacturing variances, with the exception of fixed manufacturing cost absorption variances, restructuring charges and gain on sale of assets.

Condensed consolidating guara35

Condensed consolidating guarantor financial information (Tables)	3 Months Ended
	Mar. 27, 2016
Condensed Consolidated Guarantor Financial Information [Abstract]
Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)	TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) Three Months Ended March 27, 2016 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net revenues $ — $ 258,911 $ 261,348 $ (95,366 ) $ 424,893 Cost of goods sold — 155,541 132,963 (88,758 ) 199,746 Gross profit — 103,370 128,385 (6,608 ) 225,147 Selling, general and administrative expenses 9,329 81,477 45,059 483 136,348 Research and development expenses — 6,435 5,918 — 12,353 Restructuring charges — 4,758 5,210 — 9,968 Gain on sale of assets — — (1,019 ) — (1,019 ) (Loss) income from continuing operations before interest and taxes (9,329 ) 10,700 73,217 (7,091 ) 67,497 Interest, net 33,044 (20,318 ) 978 — 13,704 (Loss) income from continuing operations before taxes (42,373 ) 31,018 72,239 (7,091 ) 53,793 (Benefit) taxes on income from continuing operations (15,848 ) 11,677 7,864 (1,080 ) 2,613 Equity in net income of consolidated subsidiaries 77,457 57,900 168 (135,525 ) — Income from continuing operations 50,932 77,241 64,543 (141,536 ) 51,180 Operating loss from discontinued operations (382 ) — — — (382 ) (Benefit) taxes on loss from discontinued operations (139 ) — 69 — (70 ) Loss from discontinued operations (243 ) — (69 ) — (312 ) Net income 50,689 77,241 64,474 (141,536 ) 50,868 Less: Income from continuing operations attributable to noncontrolling interest — — 179 — 179 Net income attributable to common shareholders 50,689 77,241 64,295 (141,536 ) 50,689 Other comprehensive income attributable to common shareholders 23,194 18,573 22,412 (40,985 ) 23,194 Comprehensive income attributable to common shareholders $ 73,883 $ 95,814 $ 86,707 $ (182,521 ) $ 73,883 Three Months Ended March 29, 2015 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net revenues $ — $ 264,161 $ 258,901 $ (93,632 ) $ 429,430 Cost of goods sold — 158,326 137,618 (89,151 ) 206,793 Gross profit — 105,835 121,283 (4,481 ) 222,637 Selling, general and administrative expenses 11,452 84,268 43,817 160 139,697 Research and development expenses — 11,127 1,757 — 12,884 Restructuring charges — 3,739 709 — 4,448 (Loss) income from continuing operations before interest and taxes (11,452 ) 6,701 75,000 (4,641 ) 65,608 Interest, net 34,360 (18,569 ) 1,212 — 17,003 (Loss) income from continuing operations before taxes (45,812 ) 25,270 73,788 (4,641 ) 48,605 (Benefit) taxes on (loss) income from continuing operations (15,293 ) 10,992 14,744 (1,111 ) 9,332 Equity in net income of consolidated subsidiaries 69,538 59,690 97 (129,325 ) — Income from continuing operations 39,019 73,968 59,141 (132,855 ) 39,273 Operating (loss) income from discontinued operations (503 ) — 4 — (499 ) Taxes on loss from discontinued operations 164 — 40 — 204 Loss from discontinued operations (667 ) — (36 ) — (703 ) Net income 38,352 73,968 59,105 (132,855 ) 38,570 Less: Income from continuing operations attributable to noncontrolling interest — — 218 — 218 Net income attributable to common shareholders 38,352 73,968 58,887 (132,855 ) 38,352 Other comprehensive loss attributable to common shareholders (81,201 ) (106,761 ) (99,728 ) 206,489 (81,201 ) Comprehensive loss attributable to common shareholders $ (42,849 ) $ (32,793 ) $ (40,841 ) $ 73,634 $ (42,849 )
Condensed Consolidating Balance Sheets	TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING BALANCE SHEETS March 27, 2016 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) ASSETS Current assets Cash and cash equivalents $ 23,992 $ 1,005 $ 367,561 $ — $ 392,558 Accounts receivable, net 2,688 3,969 264,101 3,902 274,660 Accounts receivable from consolidated subsidiaries 4,691 2,408,849 315,430 (2,728,970 ) — Inventories, net — 207,361 162,803 (31,258 ) 338,906 Prepaid expenses and other current assets 12,505 7,136 17,427 3,665 40,733 Prepaid taxes 11,045 — 20,053 — 31,098 Assets held for sale 2,901 — 4,153 — 7,054 Total current assets 57,822 2,628,320 1,151,528 (2,752,661 ) 1,085,009 Property, plant and equipment, net 2,817 170,273 145,093 — 318,183 Goodwill — 705,754 597,702 — 1,303,456 Intangibles assets, net — 752,114 436,739 — 1,188,853 Investments in affiliates 5,823,852 1,436,790 23,143 (7,283,589 ) 196 Deferred tax assets 85,243 — 6,731 (89,616 ) 2,358 Notes receivable and other amounts due from consolidated subsidiaries 1,339,835 1,688,217 — (3,028,052 ) — Other assets 22,697 6,647 16,067 — 45,411 Total assets $ 7,332,266 $ 7,388,115 $ 2,377,003 $ (13,153,918 ) $ 3,943,466 LIABILITIES AND EQUITY Current liabilities Current borrowings $ 377,898 $ — $ 43,300 $ — $ 421,198 Accounts payable 3,403 32,514 37,396 — 73,313 Accounts payable to consolidated subsidiaries 2,461,194 227,846 39,930 (2,728,970 ) — Accrued expenses 15,623 20,429 32,745 — 68,797 Current portion of contingent consideration — 7,397 — — 7,397 Payroll and benefit-related liabilities 16,749 16,724 38,558 — 72,031 Accrued interest 6,615 — 20 — 6,635 Income taxes payable — — 13,452 (752 ) 12,700 Other current liabilities 1,968 2,623 8,013 — 12,604 Total current liabilities 2,883,450 307,533 213,414 (2,729,722 ) 674,675 Long-term borrowings 641,973 — — — 641,973 Deferred tax liabilities — 376,062 35,597 (89,616 ) 322,043 Pension and other postretirement benefit liabilities 98,086 32,000 16,718 — 146,804 Noncurrent liability for uncertain tax positions 1,321 17,775 7,072 — 26,168 Notes payable and other amounts due to consolidated subsidiaries 1,612,032 1,229,786 186,234 (3,028,052 ) — Other liabilities 23,308 21,764 12,656 — 57,728 Total liabilities 5,260,170 1,984,920 471,691 (5,847,390 ) 1,869,391 Convertible notes - redeemable equity component 12,877 — — — 12,877 Mezzanine equity 12,877 — — — 12,877 Total common shareholders' equity 2,059,219 5,403,195 1,903,333 (7,306,528 ) 2,059,219 Noncontrolling interest — — 1,979 — 1,979 Total equity 2,059,219 5,403,195 1,905,312 (7,306,528 ) 2,061,198 Total liabilities and equity $ 7,332,266 $ 7,388,115 $ 2,377,003 $ (13,153,918 ) $ 3,943,466 December 31, 2015 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) ASSETS Current assets Cash and cash equivalents $ 21,612 $ — $ 316,754 $ — $ 338,366 Accounts receivable, net 2,538 4,326 251,166 4,386 262,416 Accounts receivable from consolidated subsidiaries 5,276 2,412,079 289,697 (2,707,052 ) — Inventories, net — 205,163 149,705 (24,593 ) 330,275 Prepaid expenses and other current assets 10,511 4,702 16,037 3,665 34,915 Prepaid taxes 16,686 — 14,622 (413 ) 30,895 Assets held for sale 2,901 — 4,071 — 6,972 Total current assets 59,524 2,626,270 1,042,052 (2,724,007 ) 1,003,839 Property, plant and equipment, net 2,931 174,674 138,518 — 316,123 Goodwill — 705,753 590,099 — 1,295,852 Intangibles assets, net — 762,084 437,891 — 1,199,975 Investments in affiliates 5,724,226 1,360,045 23,065 (7,107,184 ) 152 Deferred tax assets 91,432 — 8,042 (97,133 ) 2,341 Notes receivable and other amounts due from consolidated subsidiaries 1,358,446 1,658,092 — (3,016,538 ) — Other assets 22,602 6,615 24,275 — 53,492 Total assets $ 7,259,161 $ 7,293,533 $ 2,263,942 $ (12,944,862 ) $ 3,871,774 LIABILITIES AND EQUITY Current liabilities Current borrowings $ 374,050 $ — $ 43,300 $ — $ 417,350 Accounts payable 1,945 27,527 36,833 — 66,305 Accounts payable to consolidated subsidiaries 2,478,109 201,400 27,543 (2,707,052 ) — Accrued expenses 15,399 22,281 26,337 — 64,017 Current portion of contingent consideration — 7,291 — — 7,291 Payroll and benefit-related liabilities 21,617 29,305 33,736 — 84,658 Accrued interest 7,455 — 25 — 7,480 Income taxes payable — — 8,144 (85 ) 8,059 Other current liabilities 1,300 2,679 4,981 — 8,960 Total current liabilities 2,899,875 290,483 180,899 (2,707,137 ) 664,120 Long-term borrowings 641,850 — — — 641,850 Deferred tax liabilities — 376,738 36,378 (97,133 ) 315,983 Pension and other postretirement benefit liabilities 100,355 32,274 16,812 — 149,441 Noncurrent liability for uncertain tax positions 1,151 17,722 21,527 — 40,400 Notes payable and other amounts due to consolidated subsidiaries 1,585,727 1,253,189 177,622 (3,016,538 ) — Other liabilities 20,931 15,685 12,271 — 48,887 Total liabilities 5,249,889 1,986,091 445,509 (5,820,808 ) 1,860,681 Total common shareholders' equity 2,009,272 5,307,442 1,816,612 (7,124,054 ) 2,009,272 Noncontrolling interest — — 1,821 — 1,821 Total equity 2,009,272 5,307,442 1,818,433 (7,124,054 ) 2,011,093 Total liabilities and equity $ 7,259,161 $ 7,293,533 $ 2,263,942 $ (12,944,862 ) $ 3,871,774
Condensed Consolidating Statements of Cash Flows	TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Three Months Ended March 27, 2016 Parent Guarantor Non-Guarantor Condensed (Dollars in thousands) Net cash (used in) provided by operating activities from continuing operations $ (18,852 ) $ 25,624 $ 60,060 $ 66,832 Cash flows from investing activities of continuing operations: Expenditures for property, plant and equipment (5 ) (3,470 ) (4,347 ) (7,822 ) Proceeds from sale of assets — — 1,251 1,251 Net cash used in investing activities from continuing operations (5 ) (3,470 ) (3,096 ) (6,571 ) Cash flows from financing activities of continuing operations: Reduction in borrowings (9 ) — — (9 ) Net proceeds from share based compensation plans and the related tax impacts 3,180 — — 3,180 Payments for contingent consideration — (61 ) — (61 ) Dividends paid (14,179 ) — — (14,179 ) Intercompany transactions 32,371 (21,088 ) (11,283 ) — Net cash provided by (used in) financing activities from continuing operations 21,363 (21,149 ) (11,283 ) (11,069 ) Cash flows from discontinued operations: Net cash used in operating activities (126 ) — — (126 ) Net cash used in discontinued operations (126 ) — — (126 ) Effect of exchange rate changes on cash and cash equivalents — — 5,126 5,126 Net increase in cash and cash equivalents 2,380 1,005 50,807 54,192 Cash and cash equivalents at the beginning of the period 21,612 — 316,754 338,366 Cash and cash equivalents at the end of the period $ 23,992 $ 1,005 $ 367,561 $ 392,558 Three Months Ended March 29, 2015 Parent Guarantor Non-Guarantor Condensed (Dollars in thousands) Net cash (used in) provided by operating activities from continuing operations $ (55,161 ) $ 21,527 $ 75,992 $ 42,358 Cash flows from investing activities of continuing operations: Expenditures for property, plant and equipment (37 ) (7,738 ) (6,670 ) (14,445 ) Payments for businesses and intangibles acquired, net of cash acquired — — (7,375 ) (7,375 ) Net cash used in investing activities from continuing operations (37 ) (7,738 ) (14,045 ) (21,820 ) Cash flows from financing activities of continuing operations: Proceeds from new borrowings 30,000 — — 30,000 Reduction in borrowings (52 ) — — (52 ) Net proceeds from share based compensation plans and the related tax impacts (289 ) — — (289 ) Payments for contingent consideration (3,989 ) (3,989 ) Dividends paid (14,118 ) — — (14,118 ) Intercompany transactions 40,065 (9,800 ) (30,265 ) — Net cash provided by (used in) financing activities from continuing operations 55,606 (13,789 ) (30,265 ) 11,552 Cash flows from discontinued operations: Net cash used in operating activities (302 ) — (824 ) (1,126 ) Net cash used in discontinued operations (302 ) — (824 ) (1,126 ) Effect of exchange rate changes on cash and cash equivalents — — (25,441 ) (25,441 ) Net increase in cash and cash equivalents 106 — 5,417 5,523 Cash and cash equivalents at the beginning of the period 27,996 — 275,240 303,236 Cash and cash equivalents at the end of the period $ 28,102 $ — $ 280,657 $ 308,759

Restructuring charges - 2016 Ma

Restructuring charges - 2016 Manufacturing Footprint Realignment Plan (Details) - 2016 Manufacturing Footprint Realignment Plan $ in Millions	3 Months Ended
	Mar. 27, 2016USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	$ 10.9
Employee termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	10.3
Accelerated Depreciation And Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring cost related to accelerated depreciation	0.6
Minimum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	34
Restructuring costs expected cash payment	27
Minimum | Employee termination benefits
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	14
Minimum | Facility closure and other exit costs
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	2
Minimum | Accelerated Depreciation Charges
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	10
Minimum | Other
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	8
Maximum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	44
Restructuring costs expected cash payment	31
Maximum | Employee termination benefits
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	18
Maximum | Facility closure and other exit costs
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	3
Maximum | Accelerated Depreciation Charges
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	13
Maximum | Other
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	$ 10

Restructuring charges - additio

Restructuring charges - additional information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 9,968	$ 4,448
2015 Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	237	4,238
Aggregate restructuring charges incurred	6,500
Restructuring reserve	1,800
2014 Manufacturing Footprint Realignment Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(536)	$ 163
Aggregate restructuring charges incurred	10,400
Restructuring reserve	6,500
Restructuring expenses	1,600
2014 Manufacturing Footprint Realignment Plan | Accelerated Depreciation And Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring cost related to accelerated depreciation	2,100
Restructuring charges reversal	500
Restructuring expenses	$ 16,500

Restructuring charges (Detail)

Restructuring charges (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 9,968	$ 4,448
Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	9,852	3,699
Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	123	89
Contract Termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(108)	639
Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	101	21
2016 Manufacturing Footprint Realignment Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	10,347
2016 Manufacturing Footprint Realignment Plan | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	10,347
2016 Manufacturing Footprint Realignment Plan | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0
2016 Manufacturing Footprint Realignment Plan | Contract Termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0
2016 Manufacturing Footprint Realignment Plan | Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0
2015 Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	237	4,238
2015 Restructuring Program | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	43	3,550
2015 Restructuring Program | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	123	67
2015 Restructuring Program | Contract Termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(22)	621
2015 Restructuring Program | Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	93	0
2014 Manufacturing Footprint Realignment Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(536)	163
2014 Manufacturing Footprint Realignment Plan | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(538)	137
2014 Manufacturing Footprint Realignment Plan | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	22
2014 Manufacturing Footprint Realignment Plan | Contract Termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	0
2014 Manufacturing Footprint Realignment Plan | Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	2	4
Other restructuring programs - prior years
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(80)	47
Other restructuring programs - prior years | Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	12
Other restructuring programs - prior years | Facility Closure Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	0
Other restructuring programs - prior years | Contract Termination Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	(86)	18
Other restructuring programs - prior years | Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 6	$ 17

Restructuring charges by segmen

Restructuring charges by segment (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Restructuring and other impairment charges
Restructuring charges	$ 9,968	$ 4,448
Vascular North America
Restructuring and other impairment charges
Restructuring charges	4,163	2,263
Anesthesia North America
Restructuring and other impairment charges
Restructuring charges	1,875	537
Surgical North America
Restructuring and other impairment charges
Restructuring charges	(19)	23
EMEA
Restructuring and other impairment charges
Restructuring charges	3,872	(32)
Asia
Restructuring and other impairment charges
Restructuring charges	2	0
OEM
Restructuring and other impairment charges
Restructuring charges	4	0
All Other
Restructuring and other impairment charges
Restructuring charges	$ 71	$ 1,657

Inventories, net (Detail)

Inventories, net (Detail) - USD ($) $ in Thousands	Mar. 27, 2016	Dec. 31, 2015
Inventory Disclosure [Abstract]
Raw materials	$ 79,405	$ 76,037
Work-in-process	58,729	60,218
Finished goods	237,661	230,536
Inventories, gross	375,795	366,791
Less: inventory reserve	(36,889)	(36,516)
Inventories, net	$ 338,906	$ 330,275

Goodwill and other intangible41

Goodwill and other intangible assets, net Changes in carrying amount of goodwill, by reporting segment (Details) $ in Thousands	3 Months Ended
	Mar. 27, 2016USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 1,295,852
Currency translation adjustment	7,604
Goodwill, ending balance	1,303,456
Operating Segments | Vascular North America
Goodwill [Roll Forward]
Goodwill, beginning balance	345,546
Currency translation adjustment	0
Goodwill, ending balance	345,546
Operating Segments | Anesthesia North America
Goodwill [Roll Forward]
Goodwill, beginning balance	141,122
Currency translation adjustment	349
Goodwill, ending balance	141,471
Operating Segments | Surgical North America
Goodwill [Roll Forward]
Goodwill, beginning balance	250,912
Currency translation adjustment	0
Goodwill, ending balance	250,912
Operating Segments | EMEA
Goodwill [Roll Forward]
Goodwill, beginning balance	306,009
Currency translation adjustment	2,848
Goodwill, ending balance	308,857
Operating Segments | Asia
Goodwill [Roll Forward]
Goodwill, beginning balance	141,067
Currency translation adjustment	4,624
Goodwill, ending balance	145,691
Operating Segments | OEM
Goodwill [Roll Forward]
Goodwill, beginning balance	1,194
Currency translation adjustment	0
Goodwill, ending balance	1,194
All Other | All Other
Goodwill [Roll Forward]
Goodwill, beginning balance	110,002
Currency translation adjustment	(217)
Goodwill, ending balance	$ 109,785

Goodwill and other intangible42

Goodwill and other intangible assets, net Components of intangible assets (Details) - USD ($) $ in Thousands	Mar. 27, 2016	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 1,618,033	$ 1,612,646
Accumulated amortization	(429,180)	(412,671)
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	623,151	621,078
Accumulated amortization	(222,109)	(214,924)
Intellectual property
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	523,287	522,374
Accumulated amortization	(181,482)	(173,903)
Distribution rights
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	23,376	23,279
Accumulated amortization	(14,767)	(14,393)
Trade names
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	387,088	384,821
Accumulated amortization	(10,202)	(8,929)
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	2,223	2,186
Accumulated amortization	(620)	(522)
In-process research and development
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	0	0
Indefinite-lived intangible assets	$ 58,908	$ 58,908

Goodwill and other intangible43

Goodwill and other intangible assets, net - additional information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
Amortization expense of intangible assets	$ 15,357	$ 14,740
In-process research and development
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	58,908		$ 58,908
In-process research and development | Semprus Technology
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	$ 41,000

Borrowings Components of long-t

Borrowings Components of long-term debt (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 27, 2016	Dec. 31, 2015	Apr. 30, 2015	Mar. 29, 2015
Debt Instrument [Line Items]
Total borrowings	$ 1,088,932	$ 1,088,941
Less: Unamortized debt discount on 3.875% Convertible Senior Subordinated Notes due 2017	(19,532)	(22,999)
Less: Unamortized debt issuance costs	(6,229)	(6,742)
Total long-term debt	1,063,171	1,059,200
Current borrowings	(421,198)	(417,350)
Long-term borrowings	$ 641,973	641,850
Debt instrument, stated interest rate	3.875%			3.875%
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility, at a rate of 2.02% at March 27, 2016, due 2018	$ 396,000	$ 396,000
Line of credit facility interest rate	2.02%	2.02%
Securitization Program
Debt Instrument [Line Items]
Securitization program, at a rate of 1.19% at March 27, 2016	$ 43,300	$ 43,300
Debt instrument, stated interest rate	1.19%	1.19%
3.875% Convertible Senior Subordinated Notes due 2017 (1) | Senior Notes
Debt Instrument [Line Items]
3.875% Convertible Senior Subordinated Notes due 2017 (1)	$ 399,632	$ 399,641
Debt instrument, stated interest rate	3.875%	3.875%
5.25% Senior Notes due 2024 | Senior Notes
Debt Instrument [Line Items]
5.25% Senior Notes due 2024	$ 250,000	$ 250,000
Debt instrument, stated interest rate	5.25%	5.25%	5.25%

Borrowings Fair value of long t

Borrowings Fair value of long term debt (Details) - USD ($) $ in Thousands	Mar. 27, 2016	Dec. 31, 2015
Fair Value Measurements [Line Items]
Total long-term debt	$ 1,063,171	$ 1,059,200
Fair value of debt	1,683,419	1,545,781
Level 1
Fair Value Measurements [Line Items]
Fair value of debt	987,491	858,709
Level 2
Fair Value Measurements [Line Items]
Fair value of debt	$ 695,928	$ 687,072

Financial instruments - additio

Financial instruments - additional information (Detail) - USD ($)	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015	Dec. 31, 2015
Derivatives Fair Value [Line Items]
Allowance for doubtful accounts receivable	$ 8,400,000		$ 8,000,000
Current portion of allowance for doubtful accounts	1,000,000		2,000,000
Noncurrent portion of allowance for doubtful accounts	6,300,000		6,000,000
Net revenues	424,893,000	$ 429,430,000
Spain, Italy, Portugal, and Greece
Derivatives Fair Value [Line Items]
Allowance for doubtful accounts receivable	7,300,000		7,200,000
Net revenues	30,900,000	33,000,000
Net proceeds from share based compensation plans and the related tax impacts
Derivatives Fair Value [Line Items]
Ineffectiveness related to derivatives	0	$ 0
Designated as Hedging Instrument | Net proceeds from share based compensation plans and the related tax impacts | Foreign Currency Contract
Derivatives Fair Value [Line Items]
Total notional amount for all open foreign currency forward contracts	$ 144,600,000		49,500,000
Derivative duration	9 months
Forward Contracts | Not Designated as Hedging Instrument | Foreign Currency Contract
Derivatives Fair Value [Line Items]
Loss related to currency forward contracts	$ 300,000
Total notional amount for all open foreign currency forward contracts	$ 78,300,000		$ 69,100,000

Financial instruments Fair valu

Financial instruments Fair values of derivative instruments designated as hedging instruments (Details) - Net proceeds from share based compensation plans and the related tax impacts - USD ($) $ in Thousands	Mar. 27, 2016	Dec. 31, 2015
Derivatives Fair Value [Line Items]
Total asset derivatives	$ 2,511	$ 329
Total liability derivatives	1,873	1,298
Foreign Currency Contract | Prepaid Expenses and Other Current Assets
Derivatives Fair Value [Line Items]
Total asset derivatives	2,511	329
Foreign Currency Contract | Other Current Liabilities
Derivatives Fair Value [Line Items]
Total liability derivatives	1,873	1,298
Forward Contracts | Designated as Hedging Instrument | Foreign Currency Contract | Prepaid Expenses and Other Current Assets
Derivatives Fair Value [Line Items]
Total asset derivatives	2,252	285
Forward Contracts | Designated as Hedging Instrument | Foreign Currency Contract | Other Current Liabilities
Derivatives Fair Value [Line Items]
Total liability derivatives	1,705	807
Forward Contracts | Not Designated as Hedging Instrument | Foreign Currency Contract | Prepaid Expenses and Other Current Assets
Derivatives Fair Value [Line Items]
Total asset derivatives	259	44
Forward Contracts | Not Designated as Hedging Instrument | Foreign Currency Contract | Other Current Liabilities
Derivatives Fair Value [Line Items]
Total liability derivatives	$ 168	$ 491

Financial instruments After tax

Financial instruments After tax (gain)/loss reclassified from accumulated other comprehensive income into income (Details) - Forward Contracts - Net proceeds from share based compensation plans and the related tax impacts - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives qualifying as hedges, net of tax	$ 1,480	$ 44
Foreign Currency Contract
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives qualifying as hedges, net of tax	$ 1,480	$ 44

Financial instruments Aggregate

Financial instruments Aggregate accounts receivable, net of allowance for doubtful accounts (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 27, 2016	Dec. 31, 2015
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for doubtful accounts receivable	$ 8,400	$ 8,000
Spain, Italy, Portugal, and Greece
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for doubtful accounts receivable	7,300	7,200
Current and long-term accounts receivable (net of allowances of $7.3 million and $7.2 million at March 27, 2016 and December 31, 2015, respectively) in Greece, Italy, Spain and Portugal (1)	$ 70,343	$ 62,272
Percentage of total net current and long-term accounts receivable - Greece, Italy, Spain and Portugal	25.60%	23.90%
Long-term portion of accounts receivable, net	$ 9,600	$ 8,100

Fair value measurement - additi

Fair value measurement - additional information (Detail) - USD ($)	Mar. 27, 2016	Dec. 31, 2015
Fair Value Measurements [Line Items]
Fair value measurement with unobservable inputs reconciliations liability value	$ 21,145,000	$ 20,829,000
Current portion of contingent consideration	7,397,000	$ 7,291,000
Fair value measurement with unobservable inputs reconciliations other liabilities	13,700,000
Minimum
Fair Value Measurements [Line Items]
Fair value of contingent consideration liability associated with future milestone	7,000,000
Maximum
Fair Value Measurements [Line Items]
Fair value of contingent consideration liability associated with future milestone	$ 57,674,000

Fair value measurement Financia

Fair value measurement Financial assets and liabilities carried at fair value measured on recurring basis (Details) - USD ($) $ in Thousands	Mar. 27, 2016	Dec. 31, 2015
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	$ 7,007	$ 6,922
Derivative assets	2,511	329
Derivative liabilities	1,873	1,298
Contingent consideration liabilities	21,145	20,829
Quoted prices in active markets (Level 1)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	7,007	6,922
Derivative assets	0	0
Derivative liabilities	0	0
Contingent consideration liabilities	0	0
Significant other observable Inputs (Level 2)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	0	0
Derivative assets	2,511	329
Derivative liabilities	1,873	1,298
Contingent consideration liabilities	0	0
Significant unobservable Inputs (Level 3)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	0	0
Derivative assets	0	0
Derivative liabilities	0	0
Contingent consideration liabilities	$ 21,145	$ 20,829

Fair value measurement Reconcil

Fair value measurement Reconciliation of changes in three financial liabilities measured at fair value on recurring basis (Details) $ in Thousands	3 Months Ended
	Mar. 27, 2016USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 20,829
Payment	(61)
Revaluations	377
Ending balance	$ 21,145

Fair value measurement Valuatio

Fair value measurement Valuation technique and inputs used to determine fair value of assets or liabilities (Details)	3 Months Ended
	Mar. 27, 2016
Probability Of Payment
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration, weighted average	52.70%
Probability Of Payment | Minimum
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration	0.00%
Probability Of Payment | Maximum
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration	100.00%
Market Approach Valuation Technique
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration, weighted average	8.30%
Market Approach Valuation Technique | Minimum
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration	2.60%
Market Approach Valuation Technique | Maximum
Fair Value Assets And Liabilities Measured On Unobservable Inputs [Line Items]
Contingent consideration	10.00%

Changes in shareholders' equi54

Changes in shareholders' equity - additional information (Details) - $ / shares shares in Millions	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Shareholders Equity [Line Items]
Investment warrants, exercise price	$ 74.65
Conversion of convertible notes, shares issued upon conversion	3	2.3
Equity Option
Shareholders Equity [Line Items]
Weighted average antidilutive which were not included in the calculation of earnings per share	5.2	5.8
Convertible Note
Shareholders Equity [Line Items]
Weighted average antidilutive which were not included in the calculation of earnings per share	3.6	3.1

Changes in shareholders' equi55

Changes in shareholders' equity Reconciliation of basic to diluted weighted average common shares outstanding (Details) - shares shares in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Equity [Abstract]
Basic (in shares)	41,647	41,469
Dilutive effect of share-based awards (in shares)	519	467
Dilutive effect of 3.875% Convertible Notes and warrants (in shares)	6,616	5,359
Diluted (in shares)	48,782	47,295
Debt instrument, stated interest rate	3.875%	3.875%

Changes in shareholders' equi56

Changes in shareholders' equity Change in accumulated other comprehensive income , net of tax (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	$ 2,011,093
Amounts reclassified from accumulated other comprehensive (loss) income	2,586	$ 897
Ending Balance	2,061,198
Cash Flow Hedges
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(2,491)	0
Other comprehensive income (loss) before reclassifications	(50)	243
Amounts reclassified from accumulated other comprehensive (loss) income	1,530	(199)
Net current-period other comprehensive income	1,480	44
Ending Balance	(1,011)	44
Pension and Other Postretirement Benefit Plans
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(138,887)	(141,744)
Other comprehensive income (loss) before reclassifications	182	810
Amounts reclassified from accumulated other comprehensive (loss) income	1,056	1,096
Net current-period other comprehensive income	1,238	1,906
Ending Balance	(137,649)	(139,838)
Foreign Currency Translation Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(229,746)	(119,151)
Other comprehensive income (loss) before reclassifications	20,476	(83,151)
Amounts reclassified from accumulated other comprehensive (loss) income	0	0
Net current-period other comprehensive income	20,476	(83,151)
Ending Balance	(209,270)	(202,302)
Accumulated Other Comprehensive (Loss) Income
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(371,124)	(260,895)
Other comprehensive income (loss) before reclassifications	20,608	(82,098)
Amounts reclassified from accumulated other comprehensive (loss) income	2,586	897
Net current-period other comprehensive income	23,194	(81,201)
Ending Balance	$ (347,930)	$ (342,096)

Changes in shareholders' equi57

Changes in shareholders' equity Accumulated other comprehensive income into income expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cost of goods sold	$ (199,746)	$ (206,793)
Total reclassifications, net of tax	2,586	897
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax	1,871	(209)
Tax (benefit) expense	(341)	10
Total reclassifications, net of tax	1,530	(199)
Pension and Other Postretirement Benefits Plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax	1,636	1,606
Tax (benefit) expense	(580)	(510)
Total reclassifications, net of tax	1,056	1,096
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax	1,622	1,606
Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax	14	0
Foreign Currency Contract | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cost of goods sold	$ 1,871	$ (209)

Taxes on income from continui58

Taxes on income from continuing operations- additional information (Details)	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Income Tax Disclosure [Abstract]
Effective income tax rate	4.90%	19.20%

Pension and other postretirem59

Pension and other postretirement benefits - Additional Information (Detail) $ in Millions	3 Months Ended
	Mar. 27, 2016USD ($)
Compensation and Retirement Disclosure [Abstract]
Expected employer contribution for current year	$ 2.4
Employer contribution to pension plan	$ 1.1

Pension and other postretirem60

Pension and other postretirement benefits Net benefit cost of pension and postretirement benefit plans (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Pension
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 652	$ 471
Interest cost	3,920	4,486
Expected return on plan assets	(6,198)	(6,425)
Net amortization and deferral	1,579	1,530
Net benefits expense (income)	(47)	62
Other Postretirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	111	107
Interest cost	406	512
Expected return on plan assets	0	0
Net amortization and deferral	57	77
Net benefits expense (income)	$ 574	$ 696

Commitments and contingent li61

Commitments and contingent liabilities - Additional Information (Detail) - USD ($)	Dec. 05, 2014	Mar. 27, 2016
Loss Contingencies [Line Items]
Estimated litigation liability		$ 2,700,000
Parish of Calcasieu | Judicial Ruling | Compensatory Damages
Loss Contingencies [Line Items]
Damages awarded	$ 100,000
Parish of Calcasieu | Judicial Ruling | Punitive Damages
Loss Contingencies [Line Items]
Damages awarded	$ 23,000,000
Parish of Calcasieu | Judicial Ruling | Unfavorable Regulatory Action
Loss Contingencies [Line Items]
Possible loss		10,000,000
Discontinued Operations
Loss Contingencies [Line Items]
Estimated litigation liability		$ 1,500,000
Minimum
Loss Contingencies [Line Items]
Time-frame over which the accrued amounts may be paid out, in years		15 years
Maximum
Loss Contingencies [Line Items]
Time-frame over which the accrued amounts may be paid out, in years		20 years
Accrued Liabilities
Loss Contingencies [Line Items]
Waste disposed accrued liability		$ 1,200,000
Other Liability
Loss Contingencies [Line Items]
Waste disposed accrued liability		6,100,000
Construction In Progress | European Headquarters
Loss Contingencies [Line Items]
Estimated cost		16,400,000
Property, plant and equipment		$ 5,500,000

Segment information - additiona

Segment information - additional information (Details) $ in Thousands	Apr. 01, 2015segment	Mar. 27, 2016USD ($)segmentmarket	Mar. 29, 2015USD ($)
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of operating segments | segment		6
Number of end markets | market		2,000
Revenue		$ 424,893	$ 429,430
Operating profit		67,497	65,608
Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Operating profit		90,072	83,654
Unallocated expenses
Revenues from External Customers and Long-Lived Assets [Line Items]
Operating profit		(22,575)	(18,046)
Anesthesia North America and Respiratory North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of operating segments as result of split | segment	2
Vascular North America | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue		81,588	80,766
Operating profit		19,656	15,750
Anesthesia North America | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue		45,957	45,449
Operating profit		12,177	9,960
Surgical North America | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue		38,941	38,059
Operating profit		13,256	12,327
EMEA | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue		122,095	129,282
Operating profit		21,043	26,335
Asia | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue		49,156	48,529
Operating profit		13,008	8,146
OEM | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue		33,977	34,715
Operating profit		5,189	8,043
All other | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue		53,179	52,630
Operating profit		$ 5,743	$ 3,093

Condensed consolidating guara63

Condensed consolidating guarantor financial information - additional information (Detail) - USD ($) $ in Millions	Mar. 27, 2016	Dec. 31, 2015	Apr. 30, 2015	Mar. 29, 2015
Condensed Financial Statements Captions [Line Items]
Debt instrument, stated interest rate	3.875%			3.875%
Ownership percentage of subsidiaries	100.00%
Senior Notes | 5.25% Senior Notes due 2024
Condensed Financial Statements Captions [Line Items]
Senior notes			$ 250
Debt instrument, stated interest rate	5.25%	5.25%	5.25%

Condensed consolidating guara64

Condensed consolidating guarantor financial information Condensed consolidating statements of income and comprehensive income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Condensed Income Statements, Captions [Line Items]
Net revenues	$ 424,893	$ 429,430
Cost of goods sold	199,746	206,793
Gross profit	225,147	222,637
Selling, general and administrative expenses	136,348	139,697
Research and development expenses	12,353	12,884
Restructuring charges	9,968	4,448
Gain on sale of assets	(1,019)	0
Income from continuing operations before interest and taxes	67,497	65,608
Interest, net	13,704	17,003
Income from continuing operations before taxes	53,793	48,605
(Benefit) taxes on income from continuing operations	2,613	9,332
Equity in net income of consolidated subsidiaries	0	0
Income from continuing operations	51,180	39,273
Operating loss from discontinued operations	(382)	(499)
(Benefit) taxes on loss from discontinued operations	(70)	204
Loss from discontinued operations	(312)	(703)
Net income	50,868	38,570
Less: Income from continuing operations attributable to noncontrolling interest	179	218
Net income attributable to common shareholders	50,689	38,352
Other comprehensive income attributable to common shareholders	23,194	(81,201)
Comprehensive income (loss) attributable to common shareholders	73,883	(42,849)
Consolidation, Eliminations
Condensed Income Statements, Captions [Line Items]
Net revenues	(95,366)	(93,632)
Cost of goods sold	(88,758)	(89,151)
Gross profit	(6,608)	(4,481)
Selling, general and administrative expenses	483	160
Research and development expenses	0	0
Restructuring charges	0	0
Gain on sale of assets	0
Income from continuing operations before interest and taxes	(7,091)	(4,641)
Interest, net	0
Income from continuing operations before taxes	(7,091)	(4,641)
(Benefit) taxes on income from continuing operations	(1,080)	(1,111)
Equity in net income of consolidated subsidiaries	(135,525)	(129,325)
Income from continuing operations	(141,536)	(132,855)
Operating loss from discontinued operations	0	0
(Benefit) taxes on loss from discontinued operations	0	0
Loss from discontinued operations	0	0
Net income	(141,536)	(132,855)
Less: Income from continuing operations attributable to noncontrolling interest	0	0
Net income attributable to common shareholders	(141,536)	(132,855)
Other comprehensive income attributable to common shareholders	(40,985)	206,489
Comprehensive income (loss) attributable to common shareholders	(182,521)	73,634
Parent Company
Condensed Income Statements, Captions [Line Items]
Net revenues	0	0
Cost of goods sold	0	0
Gross profit	0	0
Selling, general and administrative expenses	9,329	11,452
Research and development expenses	0	0
Restructuring charges	0	0
Gain on sale of assets	0
Income from continuing operations before interest and taxes	(9,329)	(11,452)
Interest, net	33,044	34,360
Income from continuing operations before taxes	(42,373)	(45,812)
(Benefit) taxes on income from continuing operations	(15,848)	(15,293)
Equity in net income of consolidated subsidiaries	77,457	69,538
Income from continuing operations	50,932	39,019
Operating loss from discontinued operations	(382)	(503)
(Benefit) taxes on loss from discontinued operations	(139)	164
Loss from discontinued operations	(243)	(667)
Net income	50,689	38,352
Less: Income from continuing operations attributable to noncontrolling interest	0	0
Net income attributable to common shareholders	50,689	38,352
Other comprehensive income attributable to common shareholders	23,194	(81,201)
Comprehensive income (loss) attributable to common shareholders	73,883	(42,849)
Guarantor Subsidiaries
Condensed Income Statements, Captions [Line Items]
Net revenues	258,911	264,161
Cost of goods sold	155,541	158,326
Gross profit	103,370	105,835
Selling, general and administrative expenses	81,477	84,268
Research and development expenses	6,435	11,127
Restructuring charges	4,758	3,739
Gain on sale of assets	0
Income from continuing operations before interest and taxes	10,700	6,701
Interest, net	(20,318)	(18,569)
Income from continuing operations before taxes	31,018	25,270
(Benefit) taxes on income from continuing operations	11,677	10,992
Equity in net income of consolidated subsidiaries	57,900	59,690
Income from continuing operations	77,241	73,968
Operating loss from discontinued operations	0	0
(Benefit) taxes on loss from discontinued operations	0	0
Loss from discontinued operations	0	0
Net income	77,241	73,968
Less: Income from continuing operations attributable to noncontrolling interest	0	0
Net income attributable to common shareholders	77,241	73,968
Other comprehensive income attributable to common shareholders	18,573	(106,761)
Comprehensive income (loss) attributable to common shareholders	95,814	(32,793)
Non-Guarantor Subsidiaries
Condensed Income Statements, Captions [Line Items]
Net revenues	261,348	258,901
Cost of goods sold	132,963	137,618
Gross profit	128,385	121,283
Selling, general and administrative expenses	45,059	43,817
Research and development expenses	5,918	1,757
Restructuring charges	5,210	709
Gain on sale of assets	(1,019)
Income from continuing operations before interest and taxes	73,217	75,000
Interest, net	978	1,212
Income from continuing operations before taxes	72,239	73,788
(Benefit) taxes on income from continuing operations	7,864	14,744
Equity in net income of consolidated subsidiaries	168	97
Income from continuing operations	64,543	59,141
Operating loss from discontinued operations	0	4
(Benefit) taxes on loss from discontinued operations	69	40
Loss from discontinued operations	(69)	(36)
Net income	64,474	59,105
Less: Income from continuing operations attributable to noncontrolling interest	179	218
Net income attributable to common shareholders	64,295	58,887
Other comprehensive income attributable to common shareholders	22,412	(99,728)
Comprehensive income (loss) attributable to common shareholders	$ 86,707	$ (40,841)

Condensed consolidating guara65

Condensed consolidating guarantor financial information Condensed consolidating balance sheets (Details) - USD ($) $ in Thousands	Mar. 27, 2016	Dec. 31, 2015	Mar. 29, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 392,558	$ 338,366	$ 308,759	$ 303,236
Accounts receivable, net	274,660	262,416
Accounts receivable from consolidated subsidiaries	0	0
Inventories, net	338,906	330,275
Prepaid expenses and other current assets	40,733	34,915
Prepaid taxes	31,098	30,895
Assets held for sale	7,054	6,972
Total current assets	1,085,009	1,003,839
Property, plant and equipment, net	318,183	316,123
Goodwill	1,303,456	1,295,852
Intangible assets, net	1,188,853	1,199,975
Investments in affiliates	196	152
Deferred tax assets	2,358	2,341
Notes receivable and other amounts due from consolidated subsidiaries	0	0
Other assets	45,411	53,492
Total assets	3,943,466	3,871,774
Current liabilities
Current borrowings	421,198	417,350
Accounts payable	73,313	66,305
Accounts payable to consolidated subsidiaries	0	0
Accrued expenses	68,797	64,017
Current portion of contingent consideration	7,397	7,291
Payroll and benefit-related liabilities	72,031	84,658
Accrued interest	6,635	7,480
Income taxes payable	12,700	8,059
Other current liabilities	12,604	8,960
Total current liabilities	674,675	664,120
Long-term borrowings	641,973	641,850
Deferred tax liabilities	322,043	315,983
Pension and other postretirement benefit liabilities	146,804	149,441
Noncurrent liability for uncertain tax positions	26,168	40,400
Notes payable and other amounts due to consolidated subsidiaries	0	0
Other liabilities	57,728	48,887
Total liabilities	1,869,391	1,860,681
Mezzanine equity	12,877	0
Total common shareholders' equity	2,059,219	2,009,272
Noncontrolling interest	1,979	1,821
Total equity	2,061,198	2,011,093
Total liabilities and equity	3,943,466	3,871,774
Consolidation, Eliminations
Current assets
Cash and cash equivalents	0	0
Accounts receivable, net	3,902	4,386
Accounts receivable from consolidated subsidiaries	(2,728,970)	(2,707,052)
Inventories, net	(31,258)	(24,593)
Prepaid expenses and other current assets	3,665	3,665
Prepaid taxes	0	(413)
Assets held for sale	0	0
Total current assets	(2,752,661)	(2,724,007)
Property, plant and equipment, net	0	0
Goodwill	0	0
Intangible assets, net	0	0
Investments in affiliates	(7,283,589)	(7,107,184)
Deferred tax assets	(89,616)	(97,133)
Notes receivable and other amounts due from consolidated subsidiaries	(3,028,052)	(3,016,538)
Other assets	0	0
Total assets	(13,153,918)	(12,944,862)
Current liabilities
Current borrowings	0	0
Accounts payable	0	0
Accounts payable to consolidated subsidiaries	(2,728,970)	(2,707,052)
Accrued expenses	0	0
Current portion of contingent consideration	0	0
Payroll and benefit-related liabilities	0	0
Accrued interest	0	0
Income taxes payable	(752)	(85)
Other current liabilities	0	0
Total current liabilities	(2,729,722)	(2,707,137)
Long-term borrowings	0	0
Deferred tax liabilities	(89,616)	(97,133)
Pension and other postretirement benefit liabilities	0	0
Noncurrent liability for uncertain tax positions	0	0
Notes payable and other amounts due to consolidated subsidiaries	(3,028,052)	(3,016,538)
Other liabilities	0	0
Total liabilities	(5,847,390)	(5,820,808)
Mezzanine equity	0
Total common shareholders' equity	(7,306,528)	(7,124,054)
Noncontrolling interest	0	0
Total equity	(7,306,528)	(7,124,054)
Total liabilities and equity	(13,153,918)	(12,944,862)
Parent Company
Current assets
Cash and cash equivalents	23,992	21,612	28,102	27,996
Accounts receivable, net	2,688	2,538
Accounts receivable from consolidated subsidiaries	4,691	5,276
Inventories, net	0	0
Prepaid expenses and other current assets	12,505	10,511
Prepaid taxes	11,045	16,686
Assets held for sale	2,901	2,901
Total current assets	57,822	59,524
Property, plant and equipment, net	2,817	2,931
Goodwill	0	0
Intangible assets, net	0	0
Investments in affiliates	5,823,852	5,724,226
Deferred tax assets	85,243	91,432
Notes receivable and other amounts due from consolidated subsidiaries	1,339,835	1,358,446
Other assets	22,697	22,602
Total assets	7,332,266	7,259,161
Current liabilities
Current borrowings	377,898	374,050
Accounts payable	3,403	1,945
Accounts payable to consolidated subsidiaries	2,461,194	2,478,109
Accrued expenses	15,623	15,399
Current portion of contingent consideration	0	0
Payroll and benefit-related liabilities	16,749	21,617
Accrued interest	6,615	7,455
Income taxes payable	0	0
Other current liabilities	1,968	1,300
Total current liabilities	2,883,450	2,899,875
Long-term borrowings	641,973	641,850
Deferred tax liabilities	0	0
Pension and other postretirement benefit liabilities	98,086	100,355
Noncurrent liability for uncertain tax positions	1,321	1,151
Notes payable and other amounts due to consolidated subsidiaries	1,612,032	1,585,727
Other liabilities	23,308	20,931
Total liabilities	5,260,170	5,249,889
Mezzanine equity	12,877
Total common shareholders' equity	2,059,219	2,009,272
Noncontrolling interest	0	0
Total equity	2,059,219	2,009,272
Total liabilities and equity	7,332,266	7,259,161
Guarantor Subsidiaries
Current assets
Cash and cash equivalents	1,005	0	0	0
Accounts receivable, net	3,969	4,326
Accounts receivable from consolidated subsidiaries	2,408,849	2,412,079
Inventories, net	207,361	205,163
Prepaid expenses and other current assets	7,136	4,702
Prepaid taxes	0	0
Assets held for sale	0	0
Total current assets	2,628,320	2,626,270
Property, plant and equipment, net	170,273	174,674
Goodwill	705,754	705,753
Intangible assets, net	752,114	762,084
Investments in affiliates	1,436,790	1,360,045
Deferred tax assets	0	0
Notes receivable and other amounts due from consolidated subsidiaries	1,688,217	1,658,092
Other assets	6,647	6,615
Total assets	7,388,115	7,293,533
Current liabilities
Current borrowings	0	0
Accounts payable	32,514	27,527
Accounts payable to consolidated subsidiaries	227,846	201,400
Accrued expenses	20,429	22,281
Current portion of contingent consideration	7,397	7,291
Payroll and benefit-related liabilities	16,724	29,305
Accrued interest	0	0
Income taxes payable	0	0
Other current liabilities	2,623	2,679
Total current liabilities	307,533	290,483
Long-term borrowings	0	0
Deferred tax liabilities	376,062	376,738
Pension and other postretirement benefit liabilities	32,000	32,274
Noncurrent liability for uncertain tax positions	17,775	17,722
Notes payable and other amounts due to consolidated subsidiaries	1,229,786	1,253,189
Other liabilities	21,764	15,685
Total liabilities	1,984,920	1,986,091
Mezzanine equity	0
Total common shareholders' equity	5,403,195	5,307,442
Noncontrolling interest	0	0
Total equity	5,403,195	5,307,442
Total liabilities and equity	7,388,115	7,293,533
Non-Guarantor Subsidiaries
Current assets
Cash and cash equivalents	367,561	316,754	$ 280,657	$ 275,240
Accounts receivable, net	264,101	251,166
Accounts receivable from consolidated subsidiaries	315,430	289,697
Inventories, net	162,803	149,705
Prepaid expenses and other current assets	17,427	16,037
Prepaid taxes	20,053	14,622
Assets held for sale	4,153	4,071
Total current assets	1,151,528	1,042,052
Property, plant and equipment, net	145,093	138,518
Goodwill	597,702	590,099
Intangible assets, net	436,739	437,891
Investments in affiliates	23,143	23,065
Deferred tax assets	6,731	8,042
Notes receivable and other amounts due from consolidated subsidiaries	0	0
Other assets	16,067	24,275
Total assets	2,377,003	2,263,942
Current liabilities
Current borrowings	43,300	43,300
Accounts payable	37,396	36,833
Accounts payable to consolidated subsidiaries	39,930	27,543
Accrued expenses	32,745	26,337
Current portion of contingent consideration	0	0
Payroll and benefit-related liabilities	38,558	33,736
Accrued interest	20	25
Income taxes payable	13,452	8,144
Other current liabilities	8,013	4,981
Total current liabilities	213,414	180,899
Long-term borrowings	0	0
Deferred tax liabilities	35,597	36,378
Pension and other postretirement benefit liabilities	16,718	16,812
Noncurrent liability for uncertain tax positions	7,072	21,527
Notes payable and other amounts due to consolidated subsidiaries	186,234	177,622
Other liabilities	12,656	12,271
Total liabilities	471,691	445,509
Mezzanine equity	0
Total common shareholders' equity	1,903,333	1,816,612
Noncontrolling interest	1,979	1,821
Total equity	1,905,312	1,818,433
Total liabilities and equity	$ 2,377,003	$ 2,263,942

Condensed consolidating guara66

Condensed consolidating guarantor financial information Condensed consolidating statements of cash flows (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 27, 2016	Mar. 29, 2015
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net cash (used in) provided by operating activities from continuing operations	$ 66,832	$ 42,358
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(7,822)	(14,445)
Proceeds from sale of assets	1,251	0
Payments For Businesses And Intangibles Acquired Net Of Cash Acquired	0	7,375
Net cash used in investing activities from continuing operations	(6,571)	(21,820)
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings	0	30,000
Reduction in borrowings	(9)	(52)
Net proceeds from share based compensation plans and the related tax impacts	3,180	(289)
Payments for contingent consideration	(61)	(3,989)
Dividends paid	(14,179)	(14,118)
Intercompany transactions	0	0
Net cash used in financing activities from continuing operations	(11,069)	11,552
Cash flows from discontinued operations:
Net cash used in operating activities	(126)	(1,126)
Net cash used in discontinued operations	(126)	(1,126)
Effect of exchange rate changes on cash and cash equivalents	5,126	(25,441)
Net increase in cash and cash equivalents	54,192	5,523
Cash and cash equivalents at the beginning of the period	338,366	303,236
Cash and cash equivalents at the end of the period	392,558	308,759
Consolidation, Eliminations
Cash flows from discontinued operations:
Cash and cash equivalents at the beginning of the period	0
Cash and cash equivalents at the end of the period	0
Parent Company
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net cash (used in) provided by operating activities from continuing operations	(18,852)	(55,161)
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(5)	(37)
Proceeds from sale of assets	0
Payments For Businesses And Intangibles Acquired Net Of Cash Acquired		0
Net cash used in investing activities from continuing operations	(5)	(37)
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings		30,000
Reduction in borrowings	(9)	(52)
Net proceeds from share based compensation plans and the related tax impacts	3,180	(289)
Payments for contingent consideration	0
Dividends paid	(14,179)	(14,118)
Intercompany transactions	32,371	40,065
Net cash used in financing activities from continuing operations	21,363	55,606
Cash flows from discontinued operations:
Net cash used in operating activities	(126)	(302)
Net cash used in discontinued operations	(126)	(302)
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase in cash and cash equivalents	2,380	106
Cash and cash equivalents at the beginning of the period	21,612	27,996
Cash and cash equivalents at the end of the period	23,992	28,102
Guarantor Subsidiaries
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net cash (used in) provided by operating activities from continuing operations	25,624	21,527
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(3,470)	(7,738)
Proceeds from sale of assets	0
Payments For Businesses And Intangibles Acquired Net Of Cash Acquired		0
Net cash used in investing activities from continuing operations	(3,470)	(7,738)
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings		0
Reduction in borrowings	0	0
Net proceeds from share based compensation plans and the related tax impacts	0	0
Payments for contingent consideration	(61)	(3,989)
Dividends paid	0	0
Intercompany transactions	(21,088)	(9,800)
Net cash used in financing activities from continuing operations	(21,149)	(13,789)
Cash flows from discontinued operations:
Net cash used in operating activities	0	0
Net cash used in discontinued operations	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase in cash and cash equivalents	1,005	0
Cash and cash equivalents at the beginning of the period	0	0
Cash and cash equivalents at the end of the period	1,005	0
Non-Guarantor Subsidiaries
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net cash (used in) provided by operating activities from continuing operations	60,060	75,992
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(4,347)	(6,670)
Proceeds from sale of assets	1,251
Payments For Businesses And Intangibles Acquired Net Of Cash Acquired		7,375
Net cash used in investing activities from continuing operations	(3,096)	(14,045)
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings		0
Reduction in borrowings	0	0
Net proceeds from share based compensation plans and the related tax impacts	0	0
Payments for contingent consideration	0
Dividends paid	0	0
Intercompany transactions	(11,283)	(30,265)
Net cash used in financing activities from continuing operations	(11,283)	(30,265)
Cash flows from discontinued operations:
Net cash used in operating activities	0	(824)
Net cash used in discontinued operations	0	(824)
Effect of exchange rate changes on cash and cash equivalents	5,126	(25,441)
Net increase in cash and cash equivalents	50,807	5,417
Cash and cash equivalents at the beginning of the period	316,754	275,240
Cash and cash equivalents at the end of the period	$ 367,561	$ 280,657

Subsequent event (Details)

Subsequent event (Details) - USD ($) shares in Thousands	Apr. 04, 2016	Apr. 28, 2016	Mar. 27, 2016	Mar. 29, 2015	Dec. 31, 2015
Subsequent Event [Line Items]
Conversion of convertible notes, shares issued upon conversion			3,000	2,300
Amount outstanding			$ 1,063,171,000		$ 1,059,200,000
Mezzanine equity			12,877,000		$ 0
Convertible Notes Payable | Convertible Debt | Subsequent Event
Subsequent Event [Line Items]
Repurchased amount	$ 44,300,000
Convertible Notes Payable | Convertible Debt | Exchange Consideration
Subsequent Event [Line Items]
Mezzanine equity			$ 12,900,000
Convertible Notes Payable | Convertible Debt | Exchange Consideration | Subsequent Event
Subsequent Event [Line Items]
Extinguishment of debt, amount	219,200,000
Cash payment per $1,000 principal amount	1,000
Repayments of debt	220,700,000
Repayments of debt, accrued interest	$ 1,500,000
Conversion of convertible notes, shares issued upon conversion	2,170
Amount outstanding	$ 136,200,000
Loss on extinguishment of debt		$ 16,300,000
Convertible Notes Payable | Convertible Debt | Hedge Unwind Agreements and Warrant Unwind Agreements | Subsequent Event
Subsequent Event [Line Items]
Shares received from dealer counterparties	300